This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-031079-9lxhvyyb | In vitro inhibition of human influenza A virus replication by chloroquine Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Anti- malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-032222-i6gfp4me | A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus( 2019-nCoV) infected pneumonia( standard version) Drug treatment options for the 2019-new coronavirus( 2019-nCoV) Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-029112-u507i0t0 | can the SF-12 replicate results from the SF-36 longitudinal studies? |
| cord-015503-j99cgsjt | If the L type is more aggressive than the S type, why did the relative frequency of the L type decrease compared to the S type in other places after the initial breakout in Wuhan? |
| cord-252232-vgq6gjpx | Structural illustrations were prepared using the program Povscript[ 2] Evolutionary relationships between bat coronaviruses and their hosts POVScript?: a program for model and data visualization using persistence of vision raytracing Improved methods for building protein models in electron density maps and the location of errors in these models |
| cord-253457-gawn4s9g | and What Should We Do? |
| cord-256888-tdx12ccj | different respiratory treatments for different phenotypes? |
| cord-255997-oer5lxxr | from chronic viral infections to cancer SARS- CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines Chloroquine and COVID-19, where do we stand? |
| cord-029547-9ei1ram3 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Characteristics of ocular findings of patients with coronavirus disease 2019( COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-214854-ck61ja2t | A new coronavirus associated with human respiratory disease in China Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-254968-czrgzyr3 | the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-258595-bk35vxlr | Umwelt SARS- CoV-2 from faeces to wastewater treatment: What do we know? |
| cord-254395-tu4aqczj | Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? |
| cord-253665-1dn3ek34 | interferon? |
| cord-265329-bsypo08l | What are pathogens, and what have they done to and for us? |
| cord-252456-971d0sir | Pathog Dis Novel coronavirus takes flight from bats? |
| cord-266156-xmf4emln | SARS- CoV-2 serology: test, test, test, but interpret with caution COVID-19 pandemic- a focused review for clinicians Multitiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic Waiting for certainty on Covid-19 antibody tests-at what cost? |
| cord-255883-mz6nyisw | Could SARS- CoV-2-induced hyperinflammation magnify the severity of coronavirus disease( CoViD-19) leading to acute respiratory distress syndrome? |
| cord-258914-g6pv8zz9 | The current state of H5N1 vaccines and the use of 553 the ferret model for influenza therapeutic and prophylactic development Antiviral Efficacies of FDA- Approved Drugs against SARS-557 SARS- CoV-2 vaccines: should we focus on mucosal immunity? |
| cord-252389-xrdbmosj | A prospective clinical study of detailed neurological manifestations in patients with COVID-19 Comorbidity between neurological illness and psychiatric disorders Bidirectional relations among common psychiatric and neurologic comorbidities and epilepsy: do they have an impact on the course of the seizure disorder? |
| cord-252389-xrdbmosj | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-254916-y1rw9q11 | The antiviral compound remdesivir potently inhibits RNA- dependent RNA polymerase from middle East respiratory syndrome coronavirus Structural basis for inhibition of the RNA- dependent RNA polymerase from SARS- CoV-2 by remdesivir Remdesivir and SARS- CoV-2: structural requirements at both nsp12 RdRP and nsp14 exonuclease active- sites First case of 2019 novel coronavirus in the United States A rush to judgment? |
| cord-025119-201ac32t | A trial of lopinavir- ritonavir in adults hospitalized with severe covid-19 Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? |
| cord-025119-201ac32t | a tool for high- throughput crystallography of protein- ligand complexes QSAR modelling of rat acute toxicity on the basis of PASS prediction SwissADME: a free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules Optimized hydrophobic interactions and hydrogen bonding at the target- ligand interface leads the pathways of drug- designing LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein- ligand docking World Health Organization declares global emergency: a review of the 2019 novel coronavirus( COVID-19) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-256020-wrui3i2l | The importance of recognising early possible ocular manifestation and using protective eyewear Can the Coronavirus Disease 2019( COVID-19) affect the eyes? |
| cord-256020-wrui3i2l | Worldometers( https://www. worldometers.info/coronavirus/?). |
| cord-124012-5zxkd2jy | Concretely, our experiments aimed to answer the following questions: 1 What is the expected predictive performance of the various clinical predictive models in predicting( i) SARS- CoV-2 test results for presenting patients,( ii) hospital admission for SARS- CoV-2 positive patients, and( iii) ICU admission for SARS- CoV-2 positive patients? 2 Which clinical, demographic and blood analysis features were most important for the respective best encountered predictive models for each clinical prediction task? |
| cord-124012-5zxkd2jy | Concretely, our experiments aimed to answer the following questions: 1 What is the expected predictive performance of the various clinical predictive models in predicting( i) SARS- CoV-2 test results for presenting patients,( ii) hospital admission for SARS- CoV-2 positive patients, and( iii) ICU admission for SARS- CoV-2 positive patients? 2 Which clinical, demographic and blood analysis features were most important for the respective best encountered predictive models for each clinical prediction task? |
| cord-150183-zzzyewjb | Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures Virus batters some areas, why does it spare others? |
| cord-150183-zzzyewjb | How important is the fractal MZ scale? |
| cord-024317-w1ep0wq8 | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-024317-w1ep0wq8 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-253862-jl1zhg13 | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-253862-jl1zhg13 | what next? |
| cord-033780-184e64tr | ( COVID-19) CT findings: a systematic review and meta- analysis Correlation of chest CT and RT- PCR testing for coronavirus disease 2019( COVID-19) in China: a report of 1014 cases Diagnosis of the coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-033780-184e64tr | The incubation period of coronavirus disease 2019( COVID-19) from publicly reported confirmed cases: estimation and application Age- dependent effects in the transmission and control of COVID-19 epidemics Are children less susceptible to COVID-19? |
| cord-255815-5d9bqji0 | = y 0? |
| cord-255815-5d9bqji0 | a/(1? |
| cord-265322-3854ddb9 | Twelve Years after Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease Epidemiological, clinical characteristics of cases of SARS- CoV-2 infection with abnormal imaging findings Prevalence of comorbidities in the novel Wuhan coronavirus( COVID-19) infection: a systematic review and meta- analysis Natural small molecules as inhibitors of coronavirus lipid- dependent attachment to host cells: a possible strategy for reducing SARS- COV-2 infectivity? |
| cord-265322-3854ddb9 | Would a rose by another name smell as sweet? |
| cord-267115-6jqdi417 | Does the human placenta express the canonical cell entry mediators for SARS- CoV-2? |
| cord-262958-tmp6yxlv | How good are my data and what is the 693 resolution? |
| cord-260048-yis26g81 | The species 645 Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS-646 CoV-2 Could the D614 G substitution in the 648 SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-266987-ikt8r2o1 | Exclusivity testing showed that 229E, OC43 and MERS, 229E, HKU1, NL63, OC43 yielded negative results( https://www.who.int/docs/defaultsource/coronaviruse/peiris-protocol-16-1-20.pdf? |
| cord-253844-y6xdcf20 | SARS coronavirus entry into host cells through a novel clathrin- and caveolae- independent endocytic pathway Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19 The lung macrophage in SARS- CoV-2 infection: a friend or a foe? |
| cord-253844-y6xdcf20 | why 2 meters/6 feet of inter- personal distance could not be enough Consideration of the aerosol transmission for COVID-19 and public health Asymptomatic carriage and transmission of SARS- CoV-2: what do we know? |
| cord-268476-3lxsh1zz | The chronology of the 2002- 2003 SARS mini pandemic Cluster of severe acute respiratory syndrome cases among protected health care workers- Toronto Tracheostomy in a patient with severe acute respiratory syndrome Safe tracheostomy for patients with severe acute respiratory syndrome Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic More than 60 doctors in Italy have died in COVID-19 pandemic How many medical workers have contracted COVID-19? |
| cord-270550-if748w2n | Why weight? |
| cord-258268-7ypq0t3d | Could Sars- coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-258268-7ypq0t3d | Guillain- Barrè syndrome associated with SARS- CoV-2 infecion: causality or coincidence? |
| cord-264031-0y7xbgun | I deficiency? |
| cord-264031-0y7xbgun | Who is most likely to be infected with SARS- CoV-2? |
| cord-254446-yxqbe1dj | : Facts and myths Impact of corticosteroid therapy on outcomes of persons with SARS- CoV-2, SARS- CoV, or MERS- CoV infection: a systematic review and meta- analysis COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-254446-yxqbe1dj | Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS- CoV-2: an observational cohort study Viral dynamics of SARS- CoV-2 across a spectrum of disease severity in COVID-19 Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Comparisons of viral shedding time of SARS- CoV-2 of different samples in ICU and non- ICU patients Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
| cord-254446-yxqbe1dj | The facts during the third epidemic Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-268540-wrjzr3ws | ( COVID-19) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS- CoV-2: what molecular dynamics studies of virus- host interactions reveal Deployment of convalescent plasma for the prevention and treatment of COVID-19 Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-268468-036i1082 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-268468-036i1082 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-193133-puqcbf8t | Can companion animals become infected with COVID-19? |
| cord-193133-puqcbf8t | Can companion animals become infected with COVID-19? |
| cord-193133-puqcbf8t | What Does Plant- Based Vaccine Technology Offer to the Fight against COVID-19? |
| cord-261075-wqtxhiy8 | COVID-19: consider cytokine storm syndromes and immunosuppression Cytokine storms in COVID-19 cases? |
| cord-261075-wqtxhiy8 | Does SARS- CoV-2 infection cause chronic neurological complications? |
| cord-261075-wqtxhiy8 | My Clinical Case and Review of the Literature Neurologic Features in Severe SARS- CoV-2 Infection Focal status epilepticus as unique clinical feature of COVID-19: A case report Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Comparative genetic analysis of the novel coronavirus( 2019-nCoV/ SARS- CoV-2) receptor ACE2 in different populations Guillain- Barré syndrome: a century of progress Guillain Barre syndrome associated with COVID-19 infection: A case report Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-263532-q044i7ym | Back to the Future? |
| cord-263532-q044i7ym | ult s? |
| cord-273451-xnce010o | For example, if there is one remaining ventilator and several patients in need, will the individual who is experiencing homelessness and using illicit drugs be the one selected? |
| cord-274122-n9jnu2ah | deubiquitinase inhibitors blocks SARS virus replication Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-273182-djb0ozrt | Situation update worldwide Global patterns in coronavirus diversity Sars- CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? |
| cord-267134-5gz2dotn | Could BCG vaccination induce protective trained immunity for SARS- CoV-2? |
| cord-267134-5gz2dotn | Host signaling and proteolytic pathways in the resolution or the exacerbation of coronavirus( CoV-2) infection in COVID-19 disease: what therapeutic targets? |
| cord-267134-5gz2dotn | Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-274841-rcdoewwv | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-268388-kkhuzf3p | Epidemic potential or a storm in a teacup? |
| cord-268388-kkhuzf3p | What are our pharmacotherapeutic options for MERS- CoV? |
| cord-274396-l611eisi | ␣ of Middle East respiratory syndrome Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen Antimalarial drug chloroquine counteracts activation of indoleamine( 2,3)-dioxygenase activity in human PBMC Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Hydroxychloroquine for SARS- CoV-2 infection: how did we get here? |
| cord-268561-vq1uhj5i | A Prospective Cohort Study Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease Likelihood of survival of coronavirus disease Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Cutaneous small- vessel vasculitis associated with novel 2019 coronavirus SARS- CoV-2 infection( COVID-19) Cutaneous manifestations in COVID-19: a first perspective Cutaneous manifestations of COVID-19: A review of the published literature Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease( COVID-19) Pneumonia: A Multicenter Study Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-280662-gakayv6e | an update on mechanisms of physiology and pathophysiology Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-257105-vrwuaknf | May be a potential inflammatory mediator for SarS- coV-2 infection? |
| cord-257105-vrwuaknf | S: dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex Sniffing out the contributions of the olfactory tubercle to the sense of smell: Hedonics, sensory integration, and more? |
| cord-257105-vrwuaknf | coV 2 infection? |
| cord-276630-qci7khki | New uses for old drugs Drug repositioning: Re- investigating existing drugs for new therapeutic indications Are the Statins promising antifungal agents against invasive candidiasis? |
| cord-252049-rgdynmla | Are higher levels of expression of 3CL pro in MERS- CoV- infected cells necessary to allow formation of active dimer?"Are other mechanisms such as substrate- or ligand- induced dimerizations involved in activating 3CL pro? |
| cord-252049-rgdynmla | Are higher levels of expression of 3CL pro in MERS- CoV- infected cells necessary to allow formation of active dimer?"Are other mechanisms such as substrate- or ligand- induced dimerizations involved in activating 3CL pro? |
| cord-252049-rgdynmla | Is dimerization required for the catalytic activity of bacterial biotin carboxylase? |
| cord-252049-rgdynmla | the beginning of another SARS- like pandemic? |
| cord-271648-m2c5bvuj | A Review of Virus- Host Interactions Human coronaviruses: What do they cause? |
| cord-271648-m2c5bvuj | medRxiv 2020 Comparing mask fit and usability of traditional and nanofibre N95 filtering facepiece respirators before and after nursing procedures A close shave? |
| cord-268206-ino9srb6 | : 2019-nCoV Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019( COVID-19) treatment? |
| cord-268206-ino9srb6 | a systematic review Full- genome evolutionary analysis of the novel corona virus( 2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event Severe acute respiratory syndrome Obesity and COVID-19 severity in a Intranasal immunization with inactivated SARS- CoV( SARS- associated coronavirus) induced local and serum antibodies in mice Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses Nitazoxanide: a first- in- class broad- spectrumantiviral agent Nitazoxanide, a new drug candidate forthe treatment of Middle East respiratorysyndrome coronavirus Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-275454-an8xvow3 | ( SARS- CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort? |
| cord-275454-an8xvow3 | This leads to a second and possibly more important question: what does a negative or positive result mean? |
| cord-104500-m0kfom0x | Events Soluble Receptor Potentiates Receptor- Independent Infection by Murine Coronavirus Heterogeneities in the transmission of infectious agents: Implications for the design of control programs Identification of a Novel Antibody Associated with Autoimmune Pancreatitis Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? |
| cord-104500-m0kfom0x | Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV COVID-19, SARS and MERS: are they closely related? |
| cord-104500-m0kfom0x | The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China Convalescent plasma in Covid-19: Possible mechanisms of action COVID-19 âȂŤ toward a comprehensive understanding of the disease Time course quantitative detection of SARS- CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin Cannabidiol as prophylaxis for SARS- CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic Amplification of the basic reproduction number in cattle farm networks |
| cord-104500-m0kfom0x | Why Systematic Review rather than Narrative Review? |
| cord-277253-vy0mvzeb | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
| cord-283956-zgrtux7i | One Health Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-256217-fnjer0e0 | At this stage, can the ocular immune system represent a valid model upon which to rely in order to hypothesize a possible therapeutic strategy? |
| cord-256217-fnjer0e0 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-256217-fnjer0e0 | Do corticosteroids have a role in treating Ebola virus disease? |
| cord-256217-fnjer0e0 | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-270116-r2rnnsfh | Available at Comparative Performance of SARS- CoV-2 Detection Assays using Seven Different Primer/ Probe Sets and One Assay Kit Clinical laboratory and SARS- CoV-2 infection: where do we stand? |
| cord-270116-r2rnnsfh | Targeting SARS- CoV-2 Clinical evaluation of the cobas SARS- CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 Basic problems of serological laboratory diagnosis Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease( COVID-19) Analytical performances of a chemiluminescence immunoassay for 2019-nCov IgM/ IgG and antibody kinetics Assessment of immune response to SARS- CoV-2 with fully- automated MA- GLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 Detection of antibodies against SARS- CoV-2 in patients with COVID-19 Serological immunochromatographic approach in diagnosis with SARS- CoV-2 infected COVID-19 patients Good IgA bad IgG in SARS- CoV-2 infection? |
| cord-270116-r2rnnsfh | The critical role of laboratory medicine during coronavirus disease 2019( COVID-19) and other viral outbreaks Coronavirus, the"immunity license"in Veneto: carpet antibody test COVID-19 and Italy: what next? |
| cord-275252-4e3cn50u | Viruses, microRNAs and cancer RNA virus microRNA that mimics a B- cell oncomiR Viruses and microRNAs Virus- specific host miRNAs: antiviral defenses or promoters of persistent infection? |
| cord-275252-4e3cn50u | myocardial fibrosis and heart failure microRNAs in heart disease: putative novel therapeutic targets? |
| cord-291523-4dtk1kyh | Could we use this clustering result( Fig. 7F) to infer that SARS- CoV-2 might not originate in bats or pangolins? |
| cord-282058-it0ojdk3 | What are the risks of COVID-19 infection in pregnant women? |
| cord-289407-8fje16z1 | ( SARS- CoV-2) from a symptomatic patient Environmental contamination by SARS CoV-2 in a designated hospital for coronavirus disease 2019 Environmental contamination of SARS- CoV-2 in healthcare premises Investigating SARS- CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London Are hygiene standards useful in assessing infection risk? |
| cord-274141-vujx538o | Can herbal medicine assist against avian flu? |
| cord-274141-vujx538o | The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Ethnomedicinal wisdom: an approach for antiviral drug development Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus Drug repurposing for viral infectious diseases: how far are we? |
| cord-274141-vujx538o | what next? |
| cord-257958-yehnlabq | -A fatal relationship? |
| cord-257958-yehnlabq | Is copper beneficial for COVID-19 patients? |
| cord-257958-yehnlabq | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? |
| cord-257958-yehnlabq | SARS- Cov-2, bioRxiv Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| cord-257958-yehnlabq | a critical review Effects of early corticosteroid treatment on plasma SARS- associated Coronavirus RNA concentrations in adult patients Analysis of therapeutic targets for SARS- CoV-2 and discovery of potential drugs by computational methods Peripheral Blood Examination Findings in SARS- CoV-2 Infection Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 Infection Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology? |
| cord-279443-2e4gz2bo | The role of the nsp2 and nsp3 in its pathogenesis Nsp3 of coronaviruses: structures and functions of a large multi- domain protein On the origin and continuing evolution of SARS- CoV-2 Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-279443-2e4gz2bo | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-290796-x9xqqcj6 | medRxiv preprint Is recurrence possible in coronavirus disease 2019( COVID-19)? |
| cord-271781-cfv0ta10 | ) TMPRSS2 and COVID-19: serendipity or opportunity for intervention? |
| cord-271781-cfv0ta10 | Detectable SARS- CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia Detection of SARS- CoV-2 by RT- PCR in anal from patients who have recovered from coronavirus disease 2019 Isolation of 2019-nCoV from a stool specimen of a laboratory- confirmed case of the coronavirus disease Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-271781-cfv0ta10 | First confirmed detection of SARS- CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community Can SARS- CoV-2 infection be acquired in utero? |
| cord-267782-4pjfnund | Could the smoking gun in the fight against COVID-19 be the( rh)ACE-2? World Health Organization. |
| cord-267782-4pjfnund | How might this impact on policy or clinical practice in the foreseeable future? |
| cord-267782-4pjfnund | What are the new findings? ► |
| cord-267782-4pjfnund | What is already known about this subject? ► |
| cord-290290-wyx9ib7s | gp120 Interactions with alpha4beta7 Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Testing for responses to the wrong SARS- CoV-2 antigen? |
| cord-277399-0w8is9xm | The effect of human chorionic gonadotropin- based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non- obstructive azoospermia Optimization of spermatogenesis- regulating hormones in patients with non- obstructive azoospermia and its impact on sperm retrieval: a multicentre study Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non- obstructive azoospermia? |
| cord-277399-0w8is9xm | What is a clean room? |
| cord-291436-cu5o8ipw | What do we know about 767 parasites of wildlife in high biodiversity áreas with anthropogenic disturbance? |
| cord-278370-fuu20ae7 | Guillain- Barré syndrome related to COVID-19 infection Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-278370-fuu20ae7 | Should we expect neurological symptoms in the SARS- CoV-2 epidemic? |
| cord-281281-knelqmzx | A fight for supremacy Type 1 interferons and the virus- host relationship: A lesson in détente Viruses and Interferons Recent insights into emerging coronaviruses Clinical characteristics of coronavirus disease 2019 in China Coronavirus infections and immune responses Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis Complement as a target in COVID-19? |
| cord-281281-knelqmzx | Should we stimulate or suppress immune responses in COVID-19? |
| cord-288484-qy619tfg | A novel coronavirus from patients with pneumonia in China Multiple organ infection and the pathogenesis of SARS Neurologic alterations due to respiratory virus infections Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-293274-ysr1l557 | : Is Infection Along with Mycoplasma or other Bacteria Linked to Progression to a Lethal Outcome? |
| cord-268483-joiajgs4 | : what to expect for COVID-19? |
| cord-268483-joiajgs4 | : where are we? |
| cord-268483-joiajgs4 | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-268483-joiajgs4 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan A phase 3, single- arm, prospective study of remestemcel- l, ex vivo culture- expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft- versus- host disease Remestemcel- L: Human mesenchymal stem cells as an emerging therapy for Crohn's disease Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Mesoblast To Evaluate Anti- Inflammatory Cell Therapy Remestemcel- L for Treatment of Covid-19 Lung Disease Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-281684-m3m4mhye | A SARS- CoV-2 infection model in mice demonstrates protection by neutralizing antibodies Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS- CoV-2 in golden Syrian hamsters Identification of oxidative stress and Toll- like receptor 4 signaling as a key pathway of acute lung injury SARS- CoV-2 and myocardial injury: a role for Nox2? |
| cord-281684-m3m4mhye | Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019( COVID-19) and its complications Is macrophages heterogeneity important in determining COVID-19 lethality? |
| cord-262786-otxpc46a | Immediate and long- term consequences of COVID-19 infections for the development of neurological disease Cranial neuropathies and COVID-19: neurotropism and autoimmunity Large artery ischaemic stroke in severe acute respiratory syndrome( SARS) Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients? |
| cord-262786-otxpc46a | Neurological involvement in SARS- CoV-2 infection: a clinical systematic review Impact of SARS- CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? |
| cord-262786-otxpc46a | SARS- CoV-2 can induce brain and spine demyelinating lesions Cerebrovascular disease in COVID-19 Disease in COVID-19: Is there a higher risk of stroke? |
| cord-262786-otxpc46a | The cognitive consequences of the COVID-19 epidemic: collateral damage? |
| cord-262786-otxpc46a | commonly The hypothalamus as a hub for SARS- CoV-2 brain infection and pathogenesis Cerebrovascular and neurological dysfunction under the threat of COVID-19: is there a comorbid role for smoking and vaping? |
| cord-296219-zzg9hds0 | The role of lung function in brain tissue oxygenation following traumatic brain injury Brain tissue oxygen response in severe traumatic brain injury Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual- energy CT COVID-19 patients with respiratory failure: what can we learn from aviation medicine? |
| cord-293988-f5gvwjyh | An important question remains unanswered: did the cat actually die due to SARS- CoV-2 infection? |
| cord-280774-r2xm164s | A case report with histopathologic findings COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-280774-r2xm164s | The Columbus'egg? |
| cord-280774-r2xm164s | Why some children who come into contact with the SARS- CoV-2 do not develop striking respiratory symptoms but present pernio- like lesions with negativity on diagnostic tests? |
| cord-297332-rzf0cw1x | : implications for SARS Is there an ideal animal model for SARS? |
| cord-300041-1d9xu4ts | The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS- CoV-2 Contamination of SARS- CoV-2 RT- PCR probes at the oligonucleotide manufacturer Histopathology of cutaneous COVID-19 lesion: possible SARS- CoV-2 cytopathogenic effect Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? |
| cord-259603-bh198xgl | 4 G is sufficient to support cap- independent translation in the absence of eIF4E Genome- wide analysis of protein- protein interactions and involvement of viral proteins in SARS- CoV replication Nidovirus transcription: how to make sen- se …? |
| cord-259603-bh198xgl | CORONAVIRUS nsp7- 10: SMALL BUT CRITICAL REGULATORY SUBUNITS? |
| cord-259603-bh198xgl | Clearly, both the role of nsp8( primase or processivity factor?) and the initiation mechanism employed by the nsp12-RdRp require further study. |
| cord-259603-bh198xgl | The broadspectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Ribavirin's antiviral mechanism of action: lethal mutagenesis? 0 |
| cord-259603-bh198xgl | mRNA stability SARS coronavirus accessory proteins Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus- wide conservation of a replicative endoribonuclease Arterivirus Nsp1 modulates the accumulation of minus- strand templates to control the relative abundance of viral mRNAs Does form meet function in the coronavirus replicative organelle? |
| cord-296362-9vi8xwu7 | Recently, the functions of several non- structural proteins( nsps) have been determined, including a non- canonical RdRp( nsp8), a single- stranded RNA- binding protein( nsp9), a RNA- dependent RNA polymerase( nsp12), a superfamily 1-like helicase( nsp13), a 3 0? |
| cord-292152-gmru83ac | Different points from adults Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia Virological assessment of hospitalized patients with COVID-2019 Waugh's syndrome: a report of six patients Chronic Intussusception Associated with Malrotation in a Child: A Variation of Waugh's Syndrome? |
| cord-292152-gmru83ac | However, as the definition of suspected cases does not include presentations with gastrointestinal symptoms only, there is still no clear answer to the question"should we screen for SARS- CoV-2 infection in children who require admission to hospital with gastrointestinal symptoms?". |
| cord-294363-bv6xa8v8 | what lessons have we learned? |
| cord-296602-19noki6p | Different faces of regulatory DCs in homeostasis and immunity Is there an ideal animal model for SARS? |
| cord-275926-rj23z7po | Do you modify surgical indications if the patient is nCoV positive for non- emergency surgery( e.g. chronic subdural hematoma, tumors?) |
| cord-275926-rj23z7po | May we deliver neuro- oncology in difficult times( e.g. COVID-19)? |
| cord-275926-rj23z7po | Part of the Disease? |
| cord-275926-rj23z7po | you modify your modus operandi in treating aneurysmal subarachnoid hemorrhage? |
| cord-280068-rszu1c48 | /CD147 as a direct SARS- CoV-2 spike binding receptor Vanderbilt HiJAKing SARS- CoV-2? |
| cord-280068-rszu1c48 | Roche provides an update on the phase III COVACTA trial of Actemra/ RoActemra in hospitalised patients with severe COVID-19 associated pneumonia Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-280068-rszu1c48 | the Common Denominator? |
| cord-278618-7tu5c7m1 | The important issues of clinical relevance that remain to be addressed are: what is the infective dose to contaminate a person by inhalation? |
| cord-278618-7tu5c7m1 | What is the impact of air ventilation on indoor contamination during the patient hospitalization? |
| cord-278618-7tu5c7m1 | title: Sustainability of SARS- CoV-2 in aerosols: Should we worry about airborne transmission? |
| cord-298850-tgxfki7n | Why tocilizumab could be an effective treatment for severe COVID-19? FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell- induced severe of life- threatening cytokine release syndrome |
| cord-300968-dtaasxk1 | Inhibiting severe acute respiratory syndrome- associated coronavirus by small interfering RNA Old drugs as lead compounds for a new disease? |
| cord-294136-e69ao8j0 | Since asymptomatic transmission is an established fact, how many individuals in the infected population are attributed to asymptomatic transmission? |
| cord-296250-7ln7p715 | An AlphaScreen ®-based assay for high- throughput screening for specific inhibitors of nuclear import Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? |
| cord-296250-7ln7p715 | International Scientific and Technical Committee Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-300399-21xozruq | Eurosurveillance Comparative performance of SARS- CoV-2 detection assays using seven different primer- probe sets and one assay kit How to choose the right real- time RT- PCR primer sets for the SARS- CoV-2 genome detection? |
| cord-281679-xmbnpawj | Emerg Infect Dis Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-281679-xmbnpawj | a Neglected Transmission Route of SARS- CoV-2? |
| cord-305704-grzrkff9 | -What should dermatologists know? |
| cord-269289-6uog10j4 | A few small studies have demonstrated that SARS- CoV-2 can affect the kidneys directly, but it is unclear if this is a key mechanism in acute kidney injury seen in patients with SARS- CoV-2 infection? |
| cord-269289-6uog10j4 | This study claimed that hypokalaemia was prevalent amongst SARS- CoV-2 infected patients, affecting 108 of 175 patients( 62%) that had a serum potassium of 4.0 mmol/ l which is the value required for those with myocardial dysfunction.Hypokalaemia affected 62% of patients with a K less than 3.5? |
| cord-269289-6uog10j4 | Are all factual statements correct and adequately supported by citations? |
| cord-269289-6uog10j4 | Does this significantly alter management in these patients, outside of a research context? |
| cord-269289-6uog10j4 | Partly Are arguments sufficiently supported by evidence from the published literature? |
| cord-269289-6uog10j4 | What is the evidence for hypokalaemia in SARS- CoV-2 infection so far? |
| cord-303216-1pbuywz6 | Does COVID19 infect the brain? |
| cord-296986-8fuj072z | A major outbreak of severe acute respiratory syndrome in Hong Kong Molecular immune pathogenesis and diagnosis of COVID-19 Coronavirus disease 2019( COVID-19): role of chest CT in diagnosis and management Influenza seasonality: lifting the fog Research and development on therapeutic agents and vaccines for COVID-19 and Convalescent plasma: a valid option in the treatment of COVID-19? |
| cord-296986-8fuj072z | The species severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 Urbanization and humidity shape the intensity of influenza epidemics in US cities Middle east respiratory syndrome coronavirus: what does a radiologist need to know? |
| cord-298669-g2up0cfi | Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? |
| cord-279940-i2rgjpxf | In conclusion, if an increase in HEME production pathway brings increased precursor synthesis, could we routinely dose marker for lead exposure or porphyria, such as serum porphobilinogen and aminolaevulinic acid, as biomarkers in the stages of infection? |
| cord-279940-i2rgjpxf | Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-279940-i2rgjpxf | key: cord-279940-i2rgjpxf authors: Comentale, Giuseppe; Manzo, Rachele; Pilato, Emanuele title: Sars- Cov-2 interference in HEME production: is it the time for an early predictive biomarker? |
| cord-270396-3bcnnyfq | The COV- FA group had a higher rate of'Yes'responses to the questions'Are you afraid of COVID-19?','Does it bother you to think about COVID-19?','Does the concern of getting COVID-19 disrupt your sleep?','Do you worry about COVID-19 news and stories you read on social media?','Does the thought of getting COVID-19 give you palpitations?' |
| cord-270396-3bcnnyfq | The COV- FA group had a higher rate of'Yes'responses to the questions'Are you afraid of COVID-19?','Does it bother you to think about COVID-19?','Does the concern of getting COVID-19 disrupt your sleep?','Do you worry about COVID-19 news and stories you read on social media?','Does the thought of getting COVID-19 give you palpitations?' |
| cord-270396-3bcnnyfq | The COV- FA group had a higher rate of'Yes'responses to the questions'Are you afraid of COVID-19?','Does it bother you to think about COVID-19?','Does the concern of getting COVID-19 disrupt your sleep?','Do you worry about COVID-19 news and stories you read on social media?','Does the thought of getting COVID-19 give you palpitations?' |
| cord-270396-3bcnnyfq | The COV- FA group had a higher rate of'Yes'responses to the questions'Are you afraid of COVID-19?','Does it bother you to think about COVID-19?','Does the concern of getting COVID-19 disrupt your sleep?','Do you worry about COVID-19 news and stories you read on social media?','Does the thought of getting COVID-19 give you palpitations?' |
| cord-270396-3bcnnyfq | The COV- FA group had a higher rate of'Yes'responses to the questions'Are you afraid of COVID-19?','Does it bother you to think about COVID-19?','Does the concern of getting COVID-19 disrupt your sleep?','Do you worry about COVID-19 news and stories you read on social media?','Does the thought of getting COVID-19 give you palpitations?' |
| cord-298067-awo3smgp | medRxiv A new coronavirus associated with human respiratory disease in China Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS- CoV-2 infection Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-294831-pem059zk | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-294831-pem059zk | What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid- treated patients? |
| cord-256508-ce59ovan | Are reinfections less severe than the first? |
| cord-256508-ce59ovan | How does COVID-19 kill? |
| cord-256508-ce59ovan | This case lead to several open questions: How frequent is reinfection? |
| cord-256508-ce59ovan | Tracking down RNA synthesis Viral load dynamics and disease severity in patients infected with SARS- CoV-2 in Zhejiang province, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome A Novel Coronavirus from Patients with Pneumonia in China Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Treatment of hepatitis C virus infection with direct- acting antiviral agents: 100% cure? |
| cord-256508-ce59ovan | Where does the virus replicate? |
| cord-256508-ce59ovan | Will vaccine protect against reinfections? |
| cord-306177-5wefp31y | A"rule of three"for fragment- based lead discovery? |
| cord-277076-yvsyo4l9 | Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Bats, civets and the emergence of SARS Wet marketsÀA continuing source of severe acute respiratory syndrome and influenza? |
| cord-277076-yvsyo4l9 | Interest soon focused on these early index cases: was there any characteristic these patients had in common that could point to a source of their SARS- CoV infection? |
| cord-277076-yvsyo4l9 | Is the fact that the first pandemic of the twenty- first century was quickly contained reason to take comfort in the knowledge that the history of humankind has reached a phase in which biomedical sciences and information technology are able to deal with such threats? |
| cord-277076-yvsyo4l9 | The evolvability of emerging viruses Development of antiviral therapy for severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Identification of a novel coronavirus in patients with severe acute respiratory syndrome Severe acute respiratory syndrome: Identification of the etiological agent Evaluation of advanced reverse transcription- PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome- associated coronavirus Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Bats are natural reservoirs of SARS- like coronaviruses Viral zoonosesÀA threat under control? |
| cord-296426-upwsdgso | Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability- Does One Exist? |
| cord-296426-upwsdgso | Should COVID-19 Infection Be Considered? |
| cord-304306-rxjahqwh | Structural Differences Linked to Virus Characteristics? |
| cord-308110-cco3aq4n | A review of the safety of favipiravir-a potential treatment in the COVID-19 pandemic? |
| cord-287501-7it4kh0e | How can(-)-epigallocatechin gallate from green tea prevent HIV-1 infection? |
| cord-287501-7it4kh0e | The spike protein of SARS- CoV-a target for vaccine and therapeutic development Are drugs for SARS on the horizon? |
| cord-287501-7it4kh0e | genistein Effects of flavanoids on immune and inflammatory cell functions Metabolism of isoflavones in human subjects Flavonoids from carnation( Dianthus caryophyllus) and their antifungal activity Therapeutic potential of inhibition of the NF- κB pathway in the treatment of inflammation and cancer Antimicrobial activity of flavonoids Flavonoids: modulators of brain function? |
| cord-269275-b7xxk48t | Clinical Characteristics of Coronavirus Disease 2019 in China Clinical characteristics of 50 466 hospitalized patients with 2019-nCoV infection SARS diagnosis and treatment protocol Clinical analysis of 260 cases of SARS in GuangZhou Management and prevention of SARS in China Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-269275-b7xxk48t | Diagnosis and treatment of the novel coronavirus pneumonia Protection and disinfection policies against SARS- CoV-2( COVID-19) Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-269275-b7xxk48t | Looking ahead: The risk of neurologic complications due to COVID-19 Coronavirus infections and immune responses IgM in microbial infections: taken for granted? |
| cord-269275-b7xxk48t | Peripheral nerve function in sepsis and multiple organ failure ICU- acquired weakness: should medical sovereignty belong to any specialist? |
| cord-269275-b7xxk48t | Possible central nervous system infection by SARS coronavirus Diagnosis and management of sensory polyneuropathy Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-269275-b7xxk48t | neurology Human immune system variation Clinical characteristics of 2019 novel coronavirus infection in China Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| cord-304617-5ozf18lg | What lessons have we learned? |
| cord-304792-8sdxqmkb | Hypoxia activates 15- 687 PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells 688 proliferation via ERK1/2 signalling The protective and pathogenic 691 roles of IL-17 in viral infections: friend or foe? |
| cord-297599-y4lu8m4k | : over 100 M website views per year Ready to submit your research? |
| cord-297599-y4lu8m4k | Does SARS- Cov-2 invade the brain? |
| cord-309289-vm0k7hfx | Flavivirus Replication and Assembly Complexes COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-309633-1cd74xdl | Participants with ARI symptoms also had symptom duration data collected in response to the question,"When did the symptoms you mentioned in the beginning of this survey become new or worsening?" |
| cord-291397-look6ddt | : cord-291397-look6ddt authors: Roberto, Palumbo; Francesco, Londrino; Emanuela, Cordova; Giorgia, Gambardella; Pasquale, Niscola; Sara, Dominijanni title: Current treatment of COVID-19 in renal patients: hope or hype? |
| cord-291397-look6ddt | COVID-19 pneumonia: a random association? |
| cord-291397-look6ddt | Fact sheet for health care providers Emergency Use Authorization( EUA) of remdesivir( GS-5734 ™) Nucleosides for the treatment of respiratory RNA virus infections Mutagenesis in norovirus in response to Favipiravir treatment Laboratory findings, compassionate use of Favipiravir, and outcome in patients with Ebola virus disease, guinea, 2015-a retrospective observational study Drugs for influenza treatment: is there significant news? |
| cord-291397-look6ddt | The epidemiology, diagnosis and treatment of COVID-19 Chest X- ray features of SARS- CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-310807-p5cb6idp | : what's new? |
| cord-289588-n61gz7pi | COVID-19: what is next for public health? |
| cord-289588-n61gz7pi | Coronaviruses post- SARS: update on replication and 902 pathogenesis Risk 904 in vaccine research and development quantified Immunosuppression for hyperinflammation in 906 COVID-19: a double- edged sword? |
| cord-289588-n61gz7pi | How will 702 country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-289588-n61gz7pi | What we know? |
| cord-304073-f3iwclkm | Is there an ideal animal model for SARS? |
| cord-304073-f3iwclkm | What is the predictive value of animal models for vaccine efficacy in humans? |
| cord-301730-flv5lnv8 | However, was COVID-19 an unexpected viral pandemic? |
| cord-301730-flv5lnv8 | What Does Plant- Based Vaccine Technology Offer to the Fight against COVID-19? |
| cord-304418-k9owyolj | -A systematic review of the literature, case series, and recommendations for clinical assessment and management Epidemiologie und therapie in Deutschland, Österreich und der Schweiz Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease COVID-19 and anosmia: A review based on up- to- date knowledge Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Neurologic features in severe SARS- COV-2 infection Neurological manifestations and complications of COVID-19: A literature review A first Case of Meningitis/ Encephalitis associated with SARS- Coronavirus-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-304418-k9owyolj | What Is a Pandemic? |
| cord-310624-3kojrkz7 | Identifying SARS- CoV-2 related coronaviruses in Malayan pangolins Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-309876-l0xginsa | How Well Do They Actually Perform? |
| cord-312652-zhccmfgw | A novel coronavirus outbreak of global health concern A Novel Coronavirus from Patients with Pneumonia in China World Health Organization Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Development and Clinical Application of A Rapid IgM- IgG Combined Antibody Test for SARS- CoV-2 Infection Diagnosis IgM in microbial infections: taken for granted? |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-314445-4cb4a9r5 | The species 522 Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS-523 Could the D614 G substitution in the 525 SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-315064-2mgv9j6n | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Endothelial cell infection and endotheliitis in COVID-19 What is a pericyte? |
| cord-309074-pys4aa60 | What to know Virtually Perfect? |
| cord-309074-pys4aa60 | Where does telemedicine fit into otolaryngology? |
| cord-268718-tt07cwrf | ( b) Which ACE2-expressing organs are prone to SARS- CoV-2 infection? |
| cord-268718-tt07cwrf | ( c) Is higher expression level of ACE2 equal to greater COVID-19 susceptibility? |
| cord-268718-tt07cwrf | Potential T- cell and B- cell epitopes of 2019-nCoV Rapid- response vaccines- does DNA offer a solution? |
| cord-268718-tt07cwrf | The neuroinvasive potential of SARS- CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study Self- reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross- sectional study High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa SARS- CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes SARS- CoV-2: recent reports on antiviral therapies based on lopinavir/ ritonavir, darunavir/ umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia( COVID-19): an empirical study from Wuhan Remdesivir in covid-19 Vitamin effects on the immune system: vitamins a and D take centre stage Vitamin D and influenza- prevention or therapy? |
| cord-268718-tt07cwrf | Therefore, the following questions regarding ACE2 expression in relation to COVID-19 susceptibility can be asked:( a) Which parts of the body express ACE2? |
| cord-268718-tt07cwrf | driving pulses of zoonotic viruses in reservoir- host populations Global patterns in coronavirus diversity Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history Bat- to- human: spike features determining'host jump'of coronaviruses SARS- CoV, MERS- CoV, and beyond Link of a ubiquitous human coronavirus to dromedary camels Cross- host evolution of severe acute respiratory syndrome coronavirus in palm civet and human MERS coronavirus neutralizing antibodies in camels Pangolins harbor SARS- CoV-2-related coronaviruses Are pangolins the intermediate host of the 2019 novel coronavirus( 2019-nCoV)? |
| cord-268718-tt07cwrf | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-293852-r72c6584 | Could interferon- gamma be a therapeutic target for treating heart failure? |
| cord-293852-r72c6584 | Fatal Severe Acute Respiratory Syndrome is Associated with Multiorgan Involvement by Coronavirus Quantitative temporal- spatial distribution of severe acute respiratory syndromeassociated coronavirus( SARS- CoV) in post- mortem tissues SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS Preventing a Covid-19 Pandemic SARS- CoV2: should Inhibitors of the Renin- Angiotensin System be Withdrawn in Patients with COVID-19? |
| cord-293852-r72c6584 | Noncoding RNAs regulating inflammation and the cardiovascular system: are they playing a role in COVID-19? |
| cord-293852-r72c6584 | over Ready to submit your research? |
| cord-311848-8n9ee57a | 71 factors associated with COVID-19 death in 17 million patients Clinical characteristics of COVID-19- 73 infected cancer patients: a retrospective case study in three hospitals within Wuhan Clinical characteristics and outcomes of cancer 19 CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and 81 predictive factors for severe respiratory failure and death Granulocyte-83 colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? |
| cord-309474-9h9w46eq | In the real- world experiences HCL use is associated with improved glycemic control and no change in psychosocial outcomes 13. Why children with T1D attending school are often not adequately managed? |
| cord-309474-9h9w46eq | The Impact of Technology on Current Diabetes Management Diabetes care in the school setting: a position statement of the American Diabetes Association Real- world outcomes of insulin pump compared to injection therapy in a population- based sample of children with type 1 diabetes Six months of hybrid closed loop in the real- world: An evaluation of children and young adults using the 670 G system Are children and adolescents with type 1 diabetes in Saudi Arabia safe at school? |
| cord-314451-mqnqjn0c | Summary of a technical meeting 25- 26 Is there an ideal animal model for SARS? |
| cord-311847-2czqs84q | Common Findings in COVID-19 Patients First case of 2019 novel coronavirus disease with Encephalitis Guillain- Barré syndrome associated with SARS- CoV-2 infection: Causality or coincidence? |
| cord-311847-2czqs84q | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-319194-ukuia48s | Can phylogeneticists and bioinformaticians help virologists to tackle SARS- CoV( severe acute respiratory syndrome coronavirus)? |
| cord-305856-xt3zxajf | A cluster of cases of severe acute respiratory syndrome in Hong Kong Identification of severe acute respiratory syndrome in Canada Coronavirus in the United States Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records How can airborne transmission of COVID-19 indoors be minimised? |
| cord-305856-xt3zxajf | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-317355-z5tk3v3b | o o f Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces Symptoms and immunoglobulin development in hospital staff exposed to a SARS- CoV-2 outbreak Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-318316-9unfl966 | A Multibasic Cleavage Site in the Spike Protein of SARS- CoV-2 Is Essential for Infection of Human Lung Cells New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-307860-iqk1yiw4 | Emergence of novel coronavirus and COVID-19: whether to stay or die out? |
| cord-307860-iqk1yiw4 | Why is COVID-19 so mild in children? |
| cord-322811-6lebh7ca | 11 323 deaths later, how far have we come? |
| cord-323061-0i5w7vm9 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-314171-431buxxr | Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-314171-431buxxr | what to expect for COVID-19? |
| cord-321855-7b1c2xdh | A novel syndrome? |
| cord-324480-7u5lh4jx | Toward understanding the risk of secondary airborne infection: emission of respirable pathogens Droplet fate in indoor environments, or can we prevent the spread of infection? |
| cord-303741-1ou0cy5k | Does SARS- Cov-2 invade the brain? |
| cord-303741-1ou0cy5k | Why do children seem to be more protected against COVID-19? |
| cord-303741-1ou0cy5k | causes disease?). |
| cord-303741-1ou0cy5k | once there( e.g., infects neural cells? |
| cord-304263-5kddk5fa | Compared to the Single X- Chromosome in Males? |
| cord-304263-5kddk5fa | Internal and emergency medicine COVID-19 and smoking: A systematic review of the evidence How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
| cord-304263-5kddk5fa | Is Nicotine the Hidden Link? |
| cord-304263-5kddk5fa | Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-259229-e8m8m4ut | A potential approach for coronavirus infection therapy? |
| cord-259229-e8m8m4ut | Admitted to ICUs of the Lombardy Region Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-259229-e8m8m4ut | Compared to the Single X- Chromosome in Males? |
| cord-259229-e8m8m4ut | Deleterious? |
| cord-259229-e8m8m4ut | Direct regulation of interleukin-6 expression by Notch signaling in macrophages COVID-19 in the heart and the lungs: Could we"Notch"the inflammatory storm? |
| cord-259229-e8m8m4ut | Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia Urinary angiotensin- converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker Renin- Angiotensin- Aldosterone System Blockers and the Risk of Covid-19 Inhibitors of the Renin- Angiotensin- Aldosterone System and Covid-19 Renin- Angiotensin- Aldosterone System Inhibitors and Risk of Covid-19 SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS COVID-19 Illness and Heart Failure: A Missing Link? |
| cord-259229-e8m8m4ut | The COVID-19 pandemic in the USA: What might we expect? |
| cord-259229-e8m8m4ut | The cardiac renin- angiotensin system: Conceptual, or a regulator of cardiac function? |
| cord-259229-e8m8m4ut | The role of the Notch pathway The Notch pathway: A novel target for myocardial remodelling therapy? |
| cord-323666-t7cshj05 | r o o f COVID-19: what is next for public health? |
| cord-321358-plxz5mkg | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-282142-76jr4p7n | A novel coronavirus from patients with pneumonia in china Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding What are the risks of COVID-19 infection in pregnant women? |
| cord-282142-76jr4p7n | Antepartum pneumonia in pregnancy Risk factors associated with the increasing prevalence of pneumonia during pregnancy Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? |
| cord-282142-76jr4p7n | Can SARS- CoV-2 Infection Be Acquired In Utero? |
| cord-282142-76jr4p7n | Isolation of infectious SARS- CoV-2 from urine of a COVID-19 patient Enteric involvement of severe acute respiratory syndrome-Associated coronavirus infection Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? |
| cord-282142-76jr4p7n | The SARS Epidemic in Hong Kong- what lessons have we learned? |
| cord-282142-76jr4p7n | what clinical recommendations to follow? |
| cord-324557-4u8dja0n | Electron microscopy of SARS- CoV-2: a challenging task Detection of viral SARS- CoV-2 genomes and histopathological changes in endomyocardial biopsies Isolation, Sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2 Is SARS- CoV-2 transfusion transmitted? |
| cord-319184-voc0eqb9 | is faecal- oral 370 transmission of SARS- CoV-2 possible? |
| cord-310239-mmvuij3k | COVID-19) outbreak Diabetes is a risk factor for the progression and prognosis of COVID-19 A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus( 2019-nCoV) infected pneumonia( standard version) Low zinc status: a new risk factor for pneumonia in the elderly? |
| cord-310239-mmvuij3k | Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/ Hydroxychloroquine to Win Todays Battle Against COVID-19? |
| cord-310239-mmvuij3k | The nutrition CRSP: what is marginal malnutrition, and does it affect human function? |
| cord-310507-5h6egve4 | COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post- kidney Transplant Recipient Are They Just Two Children COVID-19 Cases Confused With Flu? |
| cord-310507-5h6egve4 | The presence of SARS- CoV-2 RNA in the feces of COVID-19 patients CHILDREN: IS IT TIME TO CHANGE OUR APPROACH? |
| cord-310507-5h6egve4 | a case series Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes SARS- CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19 Do children need a longer time to shed SARS- CoV-2 in stool than adults? |
| cord-322129-uyswj4ow | beringei tracking: how close do tourists get? |
| cord-322913-sq9mq6f1 | Immunosenescence and inflamm- aging as two sides of the same coin: friends or foes? |
| cord-326706-75mjs6vm | What is already known on this topic? |
| cord-316702-dj2fo8sn | Do superspreaders generate new superspreaders? |
| cord-316702-dj2fo8sn | The Problem of Herd- Immunity Herd immunity: history, theory, practice Herd immunity": a rough guide Vaccination and herd immunity: what more do we know? |
| cord-316702-dj2fo8sn | cord-316702-dj2fo8sn authors: Vignesh, Ramachandran; Shankar, Esaki M.; Velu, Vijayakumar; Thyagarajan, Sadras Panchatcharam title: Is Herd Immunity Against SARS- CoV-2 a Silver Lining? |
| cord-315685-ute3dxwu | COVID-19 cases Is there an ideal animal model for SARS? |
| cord-315685-ute3dxwu | SARS- CoV-2 receptor ACE2 is an interferon- stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues Asymptomatic and human- to- human transmission of SARS- CoV-2 in a 2-family cluster Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Histopathology and ultrastructural findings of fatal COVID-19 infections Autopsy findings and venous thromboembolism in patients with COVID-19 Offline: a global health crisis? |
| cord-324102-75v4ebag | Maria del Carmen title: SARS- COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? |
| cord-304479-uxp1kg86 | A Periodic Systematic Review and Meta- Analysis Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Is Hydroxychloroquine Safe During Pregnancy? |
| cord-304479-uxp1kg86 | A first step in understanding SARS pathogenesis Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Prosper, Inhibition of SARS- CoV-2 infections in engineered human tissues using clinical- grade soluble human Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-304479-uxp1kg86 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-304479-uxp1kg86 | Can cell therapies halt cytokine storm in severe COVID-19 patients? |
| cord-320619-r466dc5t | COVID-19: immunopathology and its implications for therapy In- silico discovery of candidate drugs against Covid-19 Coronavirus- induced membrane fusion requires the cysteine- rich domain in the spike protein Structure analysis of the receptor binding of 2019-nCoV Chloroquine and hydroxychloroquine as available weapons to fight COVID-2019 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-308252-qwoo7b1l | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-308252-qwoo7b1l | COVID-19: what has been learned and to be learned about the novel coronavirus disease Complement as a target in COVID-19? |
| cord-308252-qwoo7b1l | Intestinal permeability-- a new target for disease prevention and therapy Novel coronavirus infection and gastrointestinal tract Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-308252-qwoo7b1l | Why tocilizumab could be an effective treatment for severe COVID-19? Cytokine release syndrome. |
| cord-328000-i9tzr13z | Am I ready for CRISPR? |
| cord-294527-fct2y5vn | COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? |
| cord-294527-fct2y5vn | The spectrum of antecedent infections in Guillain- Barré syndrome: a case- control study Guillain- Barré syndrome associated with Zika virus infection Neurological complications during treatment of middle east respiratory syndrome Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-294527-fct2y5vn | based case- control study Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? |
| cord-294527-fct2y5vn | during the acute treatment phase: a series of 10 cases Factors associated with psychosis among patients with severe acute respiratory syndrome: a case- control study Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta- analysis with comparison to the COVID-19 pandemic Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-297132-lhfa9fl5 | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-297132-lhfa9fl5 | Is COVID-19 an endothelial disease? |
| cord-297132-lhfa9fl5 | a retrospective cohort study COVID-19 and its implications for thrombosis and anticoagulation Acute cerebrovascular disease following COVID-19: a single center Coagulopathy and antiphospholipid antibodies in patients with Covid-19 Large- vessel stroke as a presenting feature of Covid-19 in the young Emergency room neurology in times of COVID-19: malignant ischemic stroke and SARS- COV2 infection Lupus anticoagulant is frequent in patients with Covid-19 Is endothelial dysfunction the concealed cornerstone of COVID-19? |
| cord-297132-lhfa9fl5 | related coagulopathy: a distinct entity? |
| cord-309138-44qpk2vf | : what's next? |
| cord-309138-44qpk2vf | Complementary Altern COVID-19)? |
| cord-309138-44qpk2vf | Myth or Science? |
| cord-322957-clf8f90t | what next? |
| cord-328175-4i3cz20j | Middle East respiratory syndrome coronavirus( MERS- CoV) causes transient lower respiratory tract infection in rhesus macaques Transmission of MERS- coronavirus in household contacts Infection with MERS- CoV causes lethal pneumonia in the common marmoset Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits Prophylaxis with a MERS- CoV- specific human monoclonal antibody protects rabbits from MERS- CoV infection Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Potent neutralization of MERS- CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein A humanized neutralizing antibody against MERS- CoV targeting the receptor- binding domain of the spike protein Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS- CoV in vivo Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-262119-s6hc7fxs | 2019 Longitudinal analyses reveal immunological misfiring in severe COVID-19 Is a"Cytokine Storm"Relevant to COVID-19? |
| cord-262119-s6hc7fxs | : What do we know about children? |
| cord-262119-s6hc7fxs | : Why Children Fare Better than Adults? |
| cord-262119-s6hc7fxs | Antivirals? |
| cord-262119-s6hc7fxs | Apossible smart targeting of the autophagy pathway Open questions for harnessing autophagy- modulating drugs in the SARS- CoV-2 war: hope or hype? |
| cord-262119-s6hc7fxs | As Two Sides of the Same Coin: Friends or Foes? |
| cord-262119-s6hc7fxs | Compared to the Single X- Chromosome in Males? |
| cord-262119-s6hc7fxs | Pre- exposure prophylaxis? |
| cord-262119-s6hc7fxs | Vaccine? |
| cord-302382-eifh95zm | Immunosuppression for hyperinflammation in COVID-19: a doubleedged sword? |
| cord-302382-eifh95zm | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): The experience of clinical immunologists from China Immunosuppression for hyperinflammation in COVID-19: a doubleedged sword? |
| cord-302382-eifh95zm | Virus Research A Role for Metal- Based Drugs in Fighting Covid-19 Infection? |
| cord-302382-eifh95zm | Where Do We Stand Now? |
| cord-302382-eifh95zm | interferon responses in COVID-19 Integrated analyses of single- cell atlases reveal age, gender, and smoking status associations with cell type- specific expression of mediators of SARS- CoV-2 viral entry and highlights inflammatory programs in putative target cells DPP4 inhibition: Preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-291916-5yqc3zcx | Are they closely related? |
| cord-291916-5yqc3zcx | New evidence for an old therapeutic tool? |
| cord-291916-5yqc3zcx | The Allplex 2019-nCoV( Seegene) assay: Which performances are for SARS- CoV-2 infection diagnosis? |
| cord-291916-5yqc3zcx | The epidemiology and pathogenesis of coronavirus disease( COVID-19) outbreak Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Enteric involvement of coronaviruses: Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-291916-5yqc3zcx | What we know? |
| cord-291916-5yqc3zcx | cyclin G- associated kinase regulate hepatitis C virus entry and are potential drug targets Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-331039-qgom2e3n | Which Route Should We Take? |
| cord-328395-2cakgmsj | What Is An Inflammation? |
| cord-309147-c3ikb81g | Can Chinese medicine be used for prevention of Corona virus disease 2019( COVID-19)? |
| cord-309147-c3ikb81g | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-309147-c3ikb81g | Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-309147-c3ikb81g | hygiene reduce SARS- CoV-2 transmission? |
| cord-322908-e3gok0ot | A flavonol with multifaceted therapeutic applications? |
| cord-322908-e3gok0ot | invades host cells via a novel route: CD147-spike protein SARS- coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum Coronaviruses: an overview of their replication and pathogenesis SARS- CoV-2 infects T lymphocytes through its spike protein- mediated membrane fusion Cytokine release syndrome Breadth of concomitant immune responses prior to patient recovery: a case report of non- severe COVID-19 Neutrophil extracellular traps( NETs) as markers of disease severity in COVID-19 COVID-19: immunopathology and its implications for therapy COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-328996-3sf2i45r | COVID-19 pneumonia: different respiratory 102 treatments for different phenotypes? |
| cord-331472-kd4uxcve | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread? |
| cord-264814-v4wnmg03 | Antigenspecific human T- cell responses and T cell- dependent production of human antibodies in a humanized mouse model A mouse model of SARS- CoV-2 infection and pathogenesis Adaptation of SARS- CoV-2 in BALB/ c mice for testing vaccine efficacy Vaccine adjuvants: smart components to boost the immune system Correlates of adjuvanticity: a review on adjuvants in licensed vaccines Potential adjuvants for the development of a SARS- CoV-2 vaccine based on experimental results from similar coronaviruses Development of SARS- CoV-2 vaccines: should we focus on mucosal immunity? |
| cord-264814-v4wnmg03 | Available online at A single- dose live- attenuated YF17D- vectored SARS- CoV2 vaccine candidate DNA vaccines- how far from clinical use? |
| cord-264814-v4wnmg03 | COVID-19: are neutralizing antibodies neutralizing enough? |
| cord-264814-v4wnmg03 | Is BCG vaccination causally related to reduced COVID-19 mortality? |
| cord-264814-v4wnmg03 | Protection or Hyper- Activation? |
| cord-264814-v4wnmg03 | T Cell Adaptive Immunity: Protection, Immune Suppression or Disease Enhancement? |
| cord-264814-v4wnmg03 | The Spread of COVID-19 and the BCG Vaccine: a Natural Experiment in Reunified Germany SARS- CoV-2 rates in BCGvaccinated and unvaccinated young adults BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-264814-v4wnmg03 | With Task Force Vaccine Safety Expert A controlled human infection model of group a streptococcus pharyngitis: which strain and why? |
| cord-264814-v4wnmg03 | a six- year follow- up study Recovery from the middle east respiratory syndrome is associated with antibody and T- cell responses Immune cell profiling of COVID-19 patients in the recovery stage by single- cell sequencing Immunology of COVID-19: current state of the science Molecular basis of coronavirus virulence and vaccine development SARS vaccines: where are we? |
| cord-264814-v4wnmg03 | how first exposure shapes lifelong anti- influenza virus immune responses Original antigenic sin and respiratory syncytial virus vaccines What about the original antigenic sin of the humans versus SARS- CoV-2? |
| cord-264814-v4wnmg03 | mSphere Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| cord-325614-e9hnhzfg | Is prevention of adverse health effects on the horizon? |
| cord-325614-e9hnhzfg | The coronavirus is mutating- does it matter? |
| cord-331193-33cyvidx | Visit casereports.bmj Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-312486-rumqopg0 | Management of patients with Crohn's Disease and Ulcerative Colitis during the coronavirus disease-2019 pandemic: results of an international meeting Factors associated with COVID-19-related death using OpenSAFELY Epigenetic dysregulation of ACE2 and interferon- regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients On the alert for cytokine storm: immunopathology in COVID-19 COVID-19-induced acute respiratory failure- an exacerbation of organ- specific autoimmunity? |
| cord-312486-rumqopg0 | What has SARS- CoV-2 revealed? |
| cord-312486-rumqopg0 | an overview The Complement System in COVID-19: Friend and Foe? |
| cord-312486-rumqopg0 | medRxiv Serum IgA, IgM, and IgG responses in COVID-19 Anti- SARS- CoV IgG response in relation to disease severity of severe acute respiratory syndrome Anti- spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS- CoV infection Antibodydependent infection of human macrophages by severe acute respiratory syndrome coronavirus Molecular mechanism for antibodydependent enhancement of coronavirus entry Clinical efficiency of intravenous immunoglobulin therapy in critical patients with COVID-19: a multicenter retrospective cohort study The potential danger of suboptimal antibody responses in COVID-19 Frequency of infection in patients with Rheumatoid Arthritis compared with controls: a population study Risk of severe herpes simplex virus infection in SLE: analysis of epidemiology and risk factors analysis in Taiwan Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? |
| cord-319241-div9rzax | : Should We Worry? |
| cord-319241-div9rzax | Is it the newest spark in the TORCH? |
| cord-319241-div9rzax | What are the risks of COVID-19 infection in pregnant women? |
| cord-308857-otsrexqu | A major question remains open to date,"how can the symptoms of COVID-19 be detected in their early stages? |
| cord-308857-otsrexqu | A more specific question is whether ultra- violet( UV) light can kill coronavirus? |
| cord-308857-otsrexqu | COVID-19: A new digital dawn? |
| cord-308857-otsrexqu | Will 10 million people die a year due to antimicrobial resistance by 2050? |
| cord-308857-otsrexqu | [ 104] asked"Will 10 million people die a year due to AMR by 2050? |
| cord-335155-x9az3twa | Few obvious clues were given by the genome sequence to answer an important question: what is the origin of SARS- CoV? |
| cord-286683-mettlmhz | : what decides the outcome? |
| cord-286683-mettlmhz | Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS- CoV-2 to fragile health systems of southern hemisphere countries this winter? |
| cord-286683-mettlmhz | ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals Pediatric Patients With 2019 Coronavirus Disease in China Characteristics of pediatric SARS- CoV-2 infection and potential evidence for persistent fecal viral shedding Angiotensin- converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults Are children less susceptible to COVID-19? |
| cord-286683-mettlmhz | If clinically indicated:"Is it? |
| cord-286683-mettlmhz | Report of two cases& review of the literature Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Coronavirus in pregnancy and delivery: rapid review Coronavirus Disease 2019( COVID-19) and Pregnancy: What obstetricians need to know Guidelines for pregnant women with suspected SARS- CoV-2 infection Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
| cord-286683-mettlmhz | The convalescent sera option for containing COVID-19 Drugmaker Takeda Is Working on Coronavirus Drug Breadth of concomitant immune responses prior to patient recovery: a case report of non- severe COVID-19 A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease? |
| cord-286683-mettlmhz | The role of ultrasound lung artifacts in the diagnosis of respiratory diseases Is there a role for lung ultrasound during the COVID-19 pandemic? |
| cord-314135-udce22id | A sexually transmitted infection? |
| cord-314135-udce22id | Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa? |
| cord-314135-udce22id | Persistent infection of SARS coronavirus in colonic cells in vitro Severe acute respiratory syndrome coronavirus persistence in Vero cells Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Human Genital Cancer: Synergism Between Two Virus Infections or Synergism Between a Virus Infection and Initiating Events? |
| cord-314135-udce22id | Why do viruses cause cancer? |
| cord-311125-v9ddes3c | GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery 4 Olfactory disorders following upper respiratory tract infections Olfactory Dysfunction in COVID-19: Diagnosis and Management Is chronic rhinosinusitis caused by persistent respiratory virus infection? |
| cord-311125-v9ddes3c | What mechanistic hypotheses can explain the specific impact of SARS- CoV-2 on taste function, and which cell populations may be targeted by the virus such that their loss would lead to distorted taste? |
| cord-311125-v9ddes3c | Who should we test for COVID-19? |
| cord-311125-v9ddes3c | and TMPRSS4 promote SARS- CoV-2 infection of human small intestinal enterocytes Sour Sensing from the Tongue to the Brain Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Conductive olfactory losses in chronic rhinosinusitis? |
| cord-311125-v9ddes3c | smell reported in COVID-19( Figure 3)? |
| cord-325966-0g7a9s5z | A narrative review COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-325966-0g7a9s5z | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-336150-l8w7xk0b | hospitalists'perspective Broad- spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses Coronavirus: epidemiology, genome replication and the interactions with their hosts Characterization of the receptorbinding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Differential stepwise evolution of SARS coronavirus functional proteins in different host species Dexamethasone for COVID-19? |
| cord-331094-22366b81 | www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en Emerging virus diseases: Can we ever expect the unexpected? |
| cord-324978-9qfhsj3n | Did MERS- CoV truly emerge as a human pathogen in 2012, or were cases of cryptic infection not appreciated because of a lack of suitable diagnostic tests? |
| cord-324978-9qfhsj3n | What are the roles of bats, if any, as reservoirs of MERS- CoV? |
| cord-321918-9jwma2y6 | Human monoclonal antibodies block the binding of SARS- CoV-2 spike protein to angiotensin converting enzyme 2 receptor A human monoclonal antibody blocking SARS- CoV-2 infection Rapid selection of a human monoclonal antibody that potently neutralizes SARS- CoV-2 in two animal models Therapeutic potential of small molecules and engineered proteins What are the drugs of the future? |
| cord-321918-9jwma2y6 | Prim Care Meta- analysis: convalescent blood products for spanish influenza pneumonia: a future h5n1 treatment? |
| cord-321918-9jwma2y6 | Targeting membrane- bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus Angiotensin- converting enzyme 2: cardioprotective player in the renin- angiotensin system? |
| cord-303297-fiievwy7 | COVID-19 patients after successful treatment or recovery again become severely infected with other strains of this virus? |
| cord-303297-fiievwy7 | Even though the exact origin of the virus remains unclear, it is possible to infect a Chinese horseshoe bat or a pangolin with the SARS- CoV-2 and evaluate the success of the infection to determine the origin of the new virus responsible for the pandemic: did it come from animals or from a laboratory? |
| cord-303297-fiievwy7 | However, is it in our power to do so when the official number of diagnosed cases has already exceeded 1 million people worldwide? |
| cord-303297-fiievwy7 | Is it important today to stop the spread of infection as quickly as possible? |
| cord-303297-fiievwy7 | What about reinfection with other possible strains of people who recovered from initial infection with one strain? |
| cord-303297-fiievwy7 | What about reinfection? |
| cord-321851-ku4z34lu | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-321851-ku4z34lu | Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? |
| cord-321851-ku4z34lu | a predominant role of histones Is IL-1 a good therapeutic target in the treatment of arthritis? |
| cord-320935-3n157yl4 | : what is its fate in urban water cycle and how can the water research community respond? |
| cord-320935-3n157yl4 | COVID-19: gastrointestinal manifestations and potential fecal- oral transmission Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-320935-3n157yl4 | Put a lid on it: are faecal bio- aerosols a route of transmission for SARS- CoV-2? |
| cord-337835-78i6j11i | Evidence of person- to- person transmission within a family cluster of novel coronavirus infections An adult returned traveler from Dubai hospitalized with an influenza- like illness( ILI): Middle East Respiratory Syndrome( MERS) or influenza? |
| cord-032751-pmclolvh | If your healthcare provider strongly recommended a COVID-19 vaccine in the next year, how likely is it that you'd get vaccinated? |
| cord-032751-pmclolvh | A Bayesian meta- analysis with focus on the Ajzen- Fishbein Model in the field of environmental behavior What is herd immunity, and how does it relate to pediatric vaccination uptake? |
| cord-032751-pmclolvh | Framing HPV to influence vaccination intentions among college students Does changing behavioral intentions engender behavior change? |
| cord-032751-pmclolvh | Perceived threat to physical health was measured with a single item:"If you got infected with COVID-19, how threatening would it be to your physical health?" |
| cord-032751-pmclolvh | Personal susceptibility was measured with a single item:"how likely do you believe it is that you will get infected with COVID-19?" |
| cord-032751-pmclolvh | Reexamining the major tenets of the extended parallel process model Theory- based predictors of influenza vaccination among pregnant women Red media, blue media: Evidence of ideological selectivity in media use Americans'trust in health information sources: Trends and sociodemographic predictors HPV vaccine promotion: Does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? |
| cord-032751-pmclolvh | Results from the National Immunization Survey- Teen Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? |
| cord-032751-pmclolvh | These two vaccine intent items included"How likely is it that you'll get a COVID-19 vaccine, if it becomes available?" |
| cord-032751-pmclolvh | What are the SARS- CoV-2 vaccine behavioral intentions of adults in the U.S. when a health care provider recommends the vaccine? |
| cord-032751-pmclolvh | What are the SARS- CoV-2 vaccine behavioral intentions of adults in the U.S.? |
| cord-032751-pmclolvh | What factors are associated with SARS- CoV-2 vaccine behavioral intentions of adults in the United States? |
| cord-032751-pmclolvh | Who is to blame? |
| cord-334976-53cd16w5 | Aggregating behavior of phenolic compounds- a source of false bioassay results? |
| cord-286298-pn9nwl64 | : What is the role of radiologists? |
| cord-286298-pn9nwl64 | Are aerosol, saliva, feces, urine, and foodborne the only routes of transmission? |
| cord-286298-pn9nwl64 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-286298-pn9nwl64 | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-286298-pn9nwl64 | These unresolved questions include: What is the origin of SARS- CoV-2? |
| cord-286298-pn9nwl64 | What are the other unknown routes of transmission? |
| cord-286298-pn9nwl64 | What is the intermediate host that transmitted the virus from bats? |
| cord-286298-pn9nwl64 | Why does the virus cause severe disease and mortality in the elderly or those with co- morbidities, while it is milder in children? |
| cord-286298-pn9nwl64 | interferon signals in lung stromal cells protect from influenza virus infection Rescue fecal microbiota transplantation for antibiotic- associated diarrhea in critically ill patients Long- Term safety and efficacy of fecal microbiota transplant in active ulcerative colitis Microbiota and its role on viral evasion: Is it with us or against us? |
| cord-303517-8971aq02 | -The Editors Speak Out Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? |
| cord-303517-8971aq02 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Centro Nacional de Información de Ciencias Médicas Incidence and Severity of COVID-19 in HIV- Positive Persons Receiving Antiretroviral Therapy Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-303517-8971aq02 | Mult Scler Houndmills Basingstoke Engl COVIDa MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-303517-8971aq02 | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
| cord-303517-8971aq02 | When less is better Maintaining HIV care during the COVID-19 pandemic Biomarkers of immunosuppression Immunosuppression for the non- transplant physician: what should you know? |
| cord-303517-8971aq02 | a narrative review Attenuated early inflammatory response in solid organ recipients with COVID-19 Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-338243-njkhwkwk | Novel Wuhan( 2019-nCoV) Coronavirus A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China Technical solution for emergency treatment of medical sewage contaminated by novel coronavirus Developmental toxicity of disinfection by- product monohaloacetamides in embryo- larval stage of zebrafish Association of Occupational Exposure to Disinfectants With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union Disinfection Byproducts in Rajasthan, India: Are Trihalomethanes a Sufficient Indicator of Disinfection Byproduct Exposure in Low- Income Countries? |
| cord-333703-1ku3jc9s | The Heart in COVID-19: Primary Target or Secondary Bystander? |
| cord-333703-1ku3jc9s | different from other PVOD? |
| cord-328003-yovp8squ | What Are the Most Powerful Immunogen Design Vaccine Strategies? |
| cord-328003-yovp8squ | What Are the Most Powerful Immunogen Design Vaccine Strategies? |
| cord-338468-c0jv3i1t | The trinity of COVID-19: Immunity, inflammation and intervention On the molecular determinants of the SARS- CoV-2 attack Are the universes of antibodies and antigens symmetrical? |
| cord-330597-nftwj0d5 | Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Pulmonary Vascular Pathology in Covid-19 Pulmonary Vascular Pathology in Covid-19 SARS- CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 SARS- CoV-2: Is the liver merely a bystander to severe disease? |
| cord-330597-nftwj0d5 | SARS- CoV-2 Causes a Specific Dysfunction of the Kidney Proximal Tubule Visualization of putative coronavirus in kidney Multivesicular bodies mimicking SARS- CoV-2 in patients without COVID-19 Electron microscopic investigations in COVID-19: not all crowns are coronas Am I a coronavirus? |
| cord-335137-5qt286kc | Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites SARS- CoV-2 and the pathophysiology of coronavirus disease 2019 Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS- CoV-2 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Coronaviruses as the cause of respiratory infections WHO Declares COVID-19 a Pandemic Molecular docking as a popular tool in drug design, an in silico travel Mannose- binding lectin deficiency and respiratory tract infection Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection? |
| cord-324919-ciamusjs | ( H1N1) 2009 virus determined by carbohydrate microarray Expression of intercellular adhesion molecule-1( ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection? |
| cord-324919-ciamusjs | Interferons and viruses induce a novel truncated ACE2 isoform and not the full- length SARS- CoV-2 receptor Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? |
| cord-324919-ciamusjs | acute respiratory distress syndrome Inhibition of SARS- CoV-2 infections in engineered human tissues using clinical- grade soluble human ACE2 Decoy ACE2-expressing extracellular vesicles that competitively bind SARS- CoV-2 as a possible COVID-19 therapy Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China Apelin- potential therapy for COVID-19? |
| cord-324919-ciamusjs | severe sepsis Attenuation of pulmonary ACE2 activity impairs inactivation of des- Arg 9 bradykinin/ BKB1R axis and facilitates LPSinduced neutrophil infiltration Kallikrein- kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome Understanding the renin- angiotensin- aldosterone- SARS- CoV axis: a comprehensive review Angiotensin- converting enzyme-2: a molecular and cellular perspective Snake venom- derived bradykinin- potentiating peptides: a promising therapy for COVID-19? |
| cord-337430-c2vdnml7 | Can exercise affect immune function to increase susceptibility to infection? |
| cord-322051-89wgv100 | - what is known? |
| cord-322051-89wgv100 | A new syndrome? |
| cord-322051-89wgv100 | Does COVID19 infect the brain? |
| cord-322051-89wgv100 | Would a rose by another name smell as sweet? |
| cord-342220-lrqt2gcw | An R library for the calculation of population differentiation statistics Predicting evolution from the shape of genealogical trees Measuring asymmetry in time- stamped phylogenies A metric on phylogenetic tree shapes Characterizing and comparing phylogenies from their Laplacian spectrum A non- parametric analytic framework for within- host viral phylogenies and a test for HIV-1 founder multiplicity Diversity considerations in HIV-1 vaccine selection Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein SARS vaccines: Where are we? |
| cord-316126-j51dik7f | Aerodynamic analysis of SARS- CoV-2 in two Wuhan hospitals Is the coronavirus airborne? |
| cord-316126-j51dik7f | Can a toilet promote virus transmission? |
| cord-316126-j51dik7f | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-316126-j51dik7f | This review attempts to summarize current cumulative data on SARS- CoV-2's modes of transmission and identify gaps in research while offering preliminary answers to the question on everyone's mind: is the airborne route significant and should we modify our COVID-19 PPE recommendations for frontline workers in low- risk settings? |
| cord-316126-j51dik7f | What face mask for what use in the context of COVID-19 pandemic? |
| cord-340516-9dfaqsv7 | ( COVID-19) Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-332948-h297ukuu | Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? |
| cord-332948-h297ukuu | r o o f resolution silico assessment of potential druggable pockets on the surface of?? |
| cord-332948-h297ukuu | r o o f resolution silico assessment of potential druggable pockets on the surface of?? |
| cord-340049-6rqmc89u | : potent neutralization of SARS coronavirus Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein Characterization of the receptor- binding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Is COVID-19 receiving ADE from other coronaviruses? |
| cord-300716-urmogf97 | : what is the evidence? |
| cord-300716-urmogf97 | Does COVID19 infect the brain? |
| cord-300716-urmogf97 | Is it possible that the coronavirus was so virulent that it entered the central nervous system directly without passing through the airways? |
| cord-300716-urmogf97 | The gutmicroglia connection: implications for central nervous system diseases Nervous system damage after COVID-19 infection: presence or absence? |
| cord-300716-urmogf97 | The olfactory vector hypothesis of neurodegenerative disease: is it viable? |
| cord-300716-urmogf97 | The pathogenesis of thromboembolic disease in COVID-19 patients: could be a catastrophic antiphospholipid syndrome? |
| cord-300716-urmogf97 | potential reservoirs for COVID-19 asymptomatic infection Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection Encephalitis as a clinical manifestation of COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-339762-lh8czr0a | Do corticosteroids reduce the mortality of influenza A( H1N1) infection? |
| cord-325324-kh2aal5n | -Authors'reply Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-325324-kh2aal5n | After Myocardial Infarction Angiotensin-(1- 9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129- 3p/ PKIA pathway Antihypertensive drugs and risk of COVID-19? |
| cord-325324-kh2aal5n | The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-325324-kh2aal5n | an updated meta- analysis involving 11,051 subjects Updated understanding of the outbreak of 2019 novel coronavirus( 2019-nCoV) in Wuhan Covid-19: death rate is 0.66% and increases with age, study estimates Estimates of the severity of coronavirus disease 2019: a model- based analysis Protecting older people from COVID-19: should the United Kingdom start at age 60? |
| cord-339665-nwwutduy | : where are we? |
| cord-342383-ckswlo9o | Considering BCG vaccination to reduce the impact of COVID-19 Can existing live vaccines prevent COVID-19? OPV as Potential Protection Against COVID-19 |
| cord-319877-izn315hb | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-319877-izn315hb | Nidovirus transcription: how to make sense …? |
| cord-319877-izn315hb | The mercurial nature of neutrophils: still an enigma in ARDS? |
| cord-319877-izn315hb | The role of C5a in acute lung injury induced by highly pathogenic viral infections Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus A decade after SARS: strategies for controlling emerging coronaviruses SARS vaccines: where are we? |
| cord-340042-intxyu46 | Structural basis of receptor recognition by SARS- CoV-2 Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? |
| cord-337089-ksh62ni0 | Probable pangolin origin of SARS- CoV-2 associated with the COVID-19 outbreak Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross- species transmission from snake to human A novel bat coronavirus closely related to SARS- CoV-2 contains natural insertions at the S1/ S2 cleavage site of the spike protein Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Genomic characterization of a novel SARS- CoV-2 Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Do pets protect their owners in the COVID-19 era? |
| cord-337089-ksh62ni0 | a comparative serological study Antibodies against MERS coronavirus in dromedary camels Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe Bats may be SARS reservoir Infection and rapid transmission of SARS- CoV-2 in ferrets COVID-19, SARS and MERS: are they closely related? |
| cord-318164-6rqi17oz | ( 3) Would the use of infected cryopreserved semen affect the fertilization process[ 18, 19]? |
| cord-318164-6rqi17oz | However, apart from safety issues for the sperm bank personnel, this novel pandemic forced us to consider three major issues:( 1) does the SARS- CoV-2 virus reach the testis and the seminal fluid? |
| cord-318164-6rqi17oz | If it does,( 2) are there any long- lasting consequences of viral testicular infection? |
| cord-318164-6rqi17oz | In any case, how might SARS- CoV-2 reach the testis? |
| cord-318164-6rqi17oz | The COVID-19 pandemics: Shall we expect andrological consequences? |
| cord-318164-6rqi17oz | The novel angiotensin- converting enzyme( ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool SARS- CoV-2 pandemic and repercussions for male infertility patients: a proposal for the individualized provision of andrological services COVID-19: should we continue to cryopreserve sperm during the pandemic? |
| cord-342569-ja96xfns | COVID-19: Implications for the Cardiovascular System Cardiovascular disease and COVID-19 COVID-19 in the heart and the lungs: could we"Notch"the inflammatory storm? |
| cord-333547-88dkh6xd | State of the knowledge and research needs Computational analysis of SARS- CoV-2/ COVID-19 surveillance by wastewater- based epidemiology locally and globally: Feasibility, economy, opportunities and challenges Characteristics of pediatric SARS- CoV-2 infection and potential evidence for persistent fecal viral shedding Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Prolonged presence of SARS- CoV-2 viral RNA in faecal samples Evidence for Gastrointestinal Infection of SARS- CoV-2 COVID-19: faecal- oral transmission? |
| cord-333547-88dkh6xd | What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? |
| cord-333547-88dkh6xd | What do we know? |
| cord-338544-eph89g47 | COVID-19: is it just a lung disease? |
| cord-338544-eph89g47 | Int Forum Allergy Rhinol Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-343302-g9vcchrh | the beginning of another SARSlike pandemic? |
| cord-326017-qw4qynqv | ( COVID-19) Lessons for the Future Telemedicine in the Era of COVID-19 Artificial intelligence: Who is responsible for the diagnosis? |
| cord-326017-qw4qynqv | It Is Pneumonia? |
| cord-326017-qw4qynqv | New evidence for an old therapeutic tool? |
| cord-326017-qw4qynqv | in Human Nasopharyngeal Swab Specimens Using Field- Effect Transistor- Based Biosensor Cross- reactive Antibody Response between SARS- CoV-2 and SARS- CoV Infections Clinical Characteristics of Coronavirus Disease 2019 in China Chest radiograph vs. computed tomography scan in the evaluation for pneumonia Middle East respiratory syndrome corona virus: Can radiology be of help? |
| cord-326017-qw4qynqv | the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? |
| cord-334550-xb0alubj | Emerg Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-334550-xb0alubj | How Do the Indian SARS- CoV-2 Strains Differ From the Strains Elsewhere? |
| cord-334550-xb0alubj | So what is that"X"factor apparently safeguarding the Indian population from the wrath of this pandemic? |
| cord-346960-3empldlo | Timeline of WHO's response to COVID-19 Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019( COVID-19) Analytical performances of a chemiluminescence immunoassay for SARS- CoV-2 IgM/ IgG and antibody kinetics IgA- Ab response to spike glycoprotein of SARS- CoV-2 in patients with COVID-19: A longitudinal study Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-348696-86nbwon2 | The ocular surface and the coronavirus disease 2019: does a dual''ocular route''exist? |
| cord-324856-hf969tav | : What Lessons Have We Learned? Covid-19-Knowledge |
| cord-324856-hf969tav | Are you currently or have you been in( domestic/ home) quarantine because of COVID-19? |
| cord-324856-hf969tav | How do you feel about the quarantine? |
| cord-324856-hf969tav | How much worried are you because of COVID-19? |
| cord-324856-hf969tav | Please rate your chances of personal risk of infection with COVID-19 for each of the following? |
| cord-347767-aq9niccc | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
| cord-348899-vynk8q8c | Aggregating behavior of phenolic compounds- a source of false bioassay results? |
| cord-350352-wgppovfx | The proximal origin of SARS- CoV-2 SARS- CoV-2 is transmitted via contact and via the air between ferrets Antiviral Efficacies of FDA- Approved Drugs against SARS- CoV-2 Infection in Ferrets Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts Which animals are at risk? |
| cord-342796-f7n8sxbu | : Where Are Influenza Virus and Rhinovirus/ Enterovirus? |
| cord-342796-f7n8sxbu | Are co- infections with COVID-19 and Influenza low or underreported? |
| cord-348821-2u6ki9dv | Ottawa Hospital Research Institute Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? |
| cord-349682-kpg0vley | ) A Study of a Candidate COVID-19 Vaccine( COV001) Can a century- old TB vaccine steel the immune system against the new coronavirus? |
| cord-337712-ylqgraos | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-337712-ylqgraos | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin- like cleavage site absent in CoV of the same clade A genomic perspective on the origin and emergence of SARS- coV-2 Structure of the SARS- CoV-2 spike receptor- binding domain bound to the ACE2 receptor Structural and functional basis of SARS- coV-2 entry by using human ACE2 SARS- coV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant A pneumonia outbreak associated with a new coronavirus of probable bat origin Evolutionary origins of the SARS- CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Arepangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-337712-ylqgraos | numerous options, no certainty for a versatile virus Antivirals against Coronaviruses: candidate drugs for SARS- coV-2 treatment? |
| cord-347734-0z2kin6r | : Is There One? |
| cord-350451-lf27iuwk | Why are RNA virus mutation rates so damn high? |
| cord-352909-s11tpfoq | How stable is the virus in different environment? |
| cord-284498-54j6ys8s | -A potential transmission route for SARS- CoV-2 to humans? |
| cord-284498-54j6ys8s | : what is its fate in urban water cycle and how can the water research community respond? |
| cord-284498-54j6ys8s | Any sustainable preventive measures to curtail the scourge in low- income countries? |
| cord-284498-54j6ys8s | COVID-19 faecal- oral transmission: Are we asking the right questions? |
| cord-284498-54j6ys8s | COVID-19: faecal- oral transmission? |
| cord-284498-54j6ys8s | How can materials science contribute to fighting against the new coronavirus? |
| cord-284498-54j6ys8s | RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital Techno- economic analysis of single disinfection units and integrated disinfection systems for sewage effluent reclamation How much reduction of virus is needed for recycled water: A continuous changing need for assessment? |
| cord-284498-54j6ys8s | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-284498-54j6ys8s | The role of wastewater treatment plants as tools for SARS- CoV-2 early detection and removal Fecal transmission in COVID-19: A potential shedding route SARS- CoV-2 from faeces to wastewater treatment: What do we know? |
| cord-284498-54j6ys8s | a Paper- Based Device Trace COVID-19 Sources with Wastewater- Based Epidemiology? |
| cord-284498-54j6ys8s | some serious consequences with urban and rural water cycle COVID-19 may transmit through aerosol Evidence for gastrointestinal infection of SARS- CoV-2 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-333498-d25qfq0f | A trial of lopinavir- ritonavir in adults hospitalized with severe Covid-19 Potential interventions for novel coronavirus in China: a systematic review Induction of pro- inflammatory cytokines( IL-1 and IL-6) and lung inflammation by Coronavirus-19( COVI-19 or SARS- CoV-2): anti- inflammatory strategies Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths Does vitamin D status impact mortality from SARS- CoV-2 infection? |
| cord-333498-d25qfq0f | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-333498-d25qfq0f | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-333498-d25qfq0f | over Ready to submit your research? |
| cord-352562-qfb478sf | infections in paediatric patients on anticancer treatment e65 SARS- CoV-2 infections with emphasis on pediatric patients: a narrative review How is immunosuppressive status affecting children and adults in SARS- CoV-2 infection? |
| cord-339344-qd73h1ie | ( ii) Travel to risk areas: Have you been in a risk area( e.g. Northern Italy, Tyrol) in the last 8 weeks or have you had direct contact with a confirmed or suspected case of COVID-19? |
| cord-339344-qd73h1ie | : Have you had contact with people who had a feverish respiratory infection during the last 8 weeks? |
| cord-339344-qd73h1ie | Working outside home: Have you been working in the home office during the last 8 weeks? |
| cord-336775-d4hi9myk | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? |
| cord-336775-d4hi9myk | Insights into the structure of the coronavirion Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor Environmental Contamination and Viral Shedding in MERS Patients During MERS- CoV Outbreak in South Korea Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? |
| cord-336775-d4hi9myk | Really'Special'as Viral Reservoirs? |
| cord-336775-d4hi9myk | what can they teach us about the severe acute respiratory syndrome? |
| cord-299093-zp07aqpm | Do the SARS- CoV-2 proteins with more potent antagonistic immune functions increase virulence in humans compared to other HCoVs? |
| cord-299093-zp07aqpm | Question mark symbol(?) denotes |
| cord-299093-zp07aqpm | SARS- CoV-2 proteins with* denotes functional conservation with SARS- CoV Which animal(s) serves as the natural reservoir of SARS- CoV-2? |
| cord-299093-zp07aqpm | What are the correlates of immune protection for SARS- CoV2 and will they provide sterilizing immunity? |
| cord-299093-zp07aqpm | What are the underlying mechanisms contributing to an inadequate IFN response to SARS- CoV-2? |
| cord-299093-zp07aqpm | Which SARS- CoV-2 proteins antagonize innate and adaptive immune responses? |
| cord-299093-zp07aqpm | Why do some recovered patients fail to develop neutralizing antibodies? |
| cord-299093-zp07aqpm | Does active replication of SARS- CoV-2 in the upper respiratory tract contribute to enhanced transmissibility in humans? |
| cord-299093-zp07aqpm | Is intestinal SARS- CoV-2 infection a source of virus transmission? |
| cord-332992-8rmqg4rf | : what do we know so far? |
| cord-332992-8rmqg4rf | Front Public Health Trained immunity: a tool for reducing susceptibility to and the severity of SARS- CoV-2 infection Complement as a target in COVID-19? |
| cord-332992-8rmqg4rf | Indeed, demographic differences as well as differences in health status, health care, COVID-19 treatment and cause of death assessment( i.e. did a person die with or die from COVID-19?), may explain the differences in reported case- fatality rates between different countries. |
| cord-332992-8rmqg4rf | SARS- CoV-2 Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-332992-8rmqg4rf | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against SARS- CoV-2 infection( COVID-19): a role for iron homeostasis? |
| cord-351115-dy81dtnk | How much promising? |
| cord-334564-bqh9jkds | Evidence from a population- based eleven- year survey in Japan Is living alone"aging alone"? |
| cord-334564-bqh9jkds | If the increase in cytokine levels and the manifestation of psychiatric symptoms are related to the severity of the symptoms of SARS- CoV infection, the"cytokine storm"might also be related to the"mental health thunderstorms"seen in patients with COVID-19? |
| cord-334564-bqh9jkds | Traumatic memories, post- traumatic stress disorder and serum cortisol levels in long- term survivors of the acute respiratory distress syndrome Disrupted glucocorticoid- Immune interactions during stress response in schizophrenia Life events and high- trait reactivity together predict psychotic symptom increases in schizophrenia Increased serum interleukin-6 levels in early stages of psychosis: associations with at- risk mental states and the severity of psychotic symptoms Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population- based register study The psychological impact of quarantine and how to reduce it: rapid review of the evidence Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease( COVID-19) epidemic among the general population in china Living alone and depressive symptoms: the influence of gender, physical disability, and social support among Hispanic and non- Hispanic older adults Living alone and depression: the modifying role of the perceived neighborhood environment Living alone or with others and depressive symptoms, and effect modification by residential social cohesion among older adults in Japan: the JAGES longitudinal study Living arrangements and risk for late life depression: a meta- analysis of published literature Which is riskier for mental health, living alone or not participating in any social activity? |
| cord-334564-bqh9jkds | the epidemic and the challenges Anosmia and ageusia: common findings in COVID-19 patients Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19 A first case of meningitis/ encephalitis associated with SARS- Coronavirus-2 Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-353704-lfndq85x | Why are RNA virus mutation rates so damn high? |
| cord-287758-da11ypiy | ( COVID-19) Clinically Significant Drug Interactions with Cyclosporin Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/ Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus( MERS- CoV), and Severe Acute Respiratory Syndrome Coronavirus( SARS- CoV) Discovery and development of safe- in- man broadspectrum antiviral agents Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-287758-da11ypiy | : cord-287758-da11ypiy authors: Mônica Vitalino de Almeida, Sinara; Cleberson Santos Soares, José; Lima dos Santos, Keriolaine; Emanuel Ferreira Alves, Josival; Galdino Ribeiro, Amélia; Trindade Tenório Jacob, Íris; Juliane da Silva Ferreira, Cindy; Celerino dos Santos, Jéssica; Ferreira de Oliveira, Jamerson; Bezerra de Carvalho Junior, Luiz; do Carmo Alves de Lima, Maria title: COVID-19 therapy: what weapons do we bring into battle? |
| cord-287758-da11ypiy | A Review of Its Use in the Management of HIV-1 Infection Discovering drugs to treat coronavirus disease 2019( COVID-19) Therapeutic Options and Critical Care Strategies in COVID-19 Patients; Where Do We Stand in This Battle? |
| cord-287758-da11ypiy | A new trick for an old drug? |
| cord-287758-da11ypiy | Antiviral treatment of COVID-19 Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment? |
| cord-287758-da11ypiy | Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-287758-da11ypiy | Engineering an antiviral for COVID-19? |
| cord-287758-da11ypiy | How Far Are We? |
| cord-287758-da11ypiy | The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| cord-287758-da11ypiy | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-287758-da11ypiy | The world is facing a huge challenge in the coronavirus disease( COVID-19) pandemic: How to fight an enemy without weapons in terms of therapy? |
| cord-317952-4oa9hfb4 | All rights reserved Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease Upregulation of circulating components of the alternative renin- angiotensin system in inflammatory bowel disease: A pilot study Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-317952-4oa9hfb4 | COVID-19 concern nephrologists? |
| cord-317952-4oa9hfb4 | Covid-19: risk factors for severe disease and death Cyclosporin A inhibits the replication of diverse coronaviruses COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-317952-4oa9hfb4 | Preventing a covid-19 pandemic Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-317952-4oa9hfb4 | Renin- angiotensin- aldosterone system inhibitors in patients with Covid-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-317952-4oa9hfb4 | Why and to what extent? |
| cord-317952-4oa9hfb4 | causative or coincidental? |
| cord-317952-4oa9hfb4 | induced pneumonia and macrophage activation syndrome- like disease A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease Tocilizumab treatment in COVID-19: A single center experience Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab Off- label use of tocilizumab in patients with SARS- CoV-2 infection Preventing COVID-19-induced pneumonia with anticytokine therapy Baricitinib for COVID-19: a suitable teatment? |
| cord-311762-f6muhf3d | And how are different results assembled? |
| cord-311762-f6muhf3d | Are all the source data underlying the results available to ensure full reproducibility? |
| cord-311762-f6muhf3d | Could the authors explain? |
| cord-311762-f6muhf3d | How is the hits( reported in Table 3) used? |
| cord-311762-f6muhf3d | How is this considered in the virtual screening? |
| cord-311762-f6muhf3d | If applicable, is the statistical analysis and its interpretation appropriate? |
| cord-311762-f6muhf3d | What are the difference? |
| cord-311762-f6muhf3d | What does the"( B Top scorers)"mean? |
| cord-311762-f6muhf3d | What's the binding energy cutoff used? |
| cord-311762-f6muhf3d | What's the binding energy cutoff used? |
| cord-328289-3h3kmjlz | Can Covid Damage the Brain? |
| cord-328289-3h3kmjlz | Does the brain contribute to respiratory failure and hypertension? |
| cord-328289-3h3kmjlz | Does the brain contribute to the immune dysregulation? |
| cord-328289-3h3kmjlz | Here are some of the outstanding questions: Do the neurological manifestations of COVID-19 reflect brain invasion? |
| cord-328289-3h3kmjlz | What are the long- term neurological and neuropsychiatric consequences of COVID-19? |
| cord-348192-ibohbjfb | ( SARS- CoV-2) viral RNA in septic tanks of fangcang hospital Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission COVID-19 faecal- oral transmission: are we asking the right questions? |
| cord-348192-ibohbjfb | Could Water and Sanitation Shortfalls Exacerbate SARS- CoV-2 Transmission Risks? |
| cord-348192-ibohbjfb | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-348384-8cvt1fo6 | In response to the question"Are you afraid of getting infected with COVID-19?"more than half( 55.2%) of HCWs responded"no"compared to their unemployed( 46.4%) or non- HCW counterparts( 44.3%, p<0.0001). |
| cord-348384-8cvt1fo6 | In response to the question"Are you afraid of getting infected with SARS- COV-2?" |
| cord-348384-8cvt1fo6 | Regarding preparations, we asked"have you stocked up on food for current situation related to coronavirus epidemic?" |
| cord-289535-srrfr1es | CD8+ T- cell responses after rAd5 boost in a randomized clinical trial BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-289535-srrfr1es | Can existing live vaccines prevent COVID-19? |
| cord-289535-srrfr1es | Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-289535-srrfr1es | How immune T- cell augmentation can help prevent COVID-19: a possible nutritional solution using ketogenic lifestyle jri/ vol4without altering disease transmission work? |
| cord-289535-srrfr1es | How to achieve equitable global distribution? |
| cord-289535-srrfr1es | Is human challenge part of the pathway to a licensed product? |
| cord-289535-srrfr1es | Is there an ideal animal model for SARS? |
| cord-289535-srrfr1es | Mammalian microRNAs predominantly act to decrease target mRNA levels AU- rich elements and associated factors: are there unifying principles? |
| cord-289535-srrfr1es | Nonspecific protection of mice against influenza virus infection by local or systemic immunization with bacille Calmette- Guerin Is global BCG vaccination coverage relevant to the progression of SARS- CoV-2 pandemic? |
| cord-289535-srrfr1es | What is the risk of immunopathology? |
| cord-289535-srrfr1es | Why Norwood? |
| cord-350505-uh8r2vyz | Aging and the Microbiome: Implications for Asthma in the Elderly? |
| cord-350505-uh8r2vyz | Krajmalnik- Brown, R. Human Gut Microbiota in Obesity and after Gastric Bypass Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes Are Significant False Negatives in the Usually Sensitive RT- PCR Detection of SARS- CoV2 Happening as the Usually RNA- Stranded Bacteria is now DNA within a Bacteria( Prevotella?) |
| cord-350505-uh8r2vyz | The Influence of Commensal Bacteria on Infection with Enteric Viruses Nutrition and the Gut Microbiome in the Elderly Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly Do Chronic Respiratory Diseases or Their Treatment Affect the Risk of SARS- CoV-2 Infection? |
| cord-352123-0bflqj1c | Potential role for zoonotic spread of COVID-19 in older adults? |
| cord-352123-0bflqj1c | e w Y o rk Dogs caught coronavirus from their owners, genetic analysis suggests Infection of dogs with SARS- CoV-2 Vertebral heart scores in eight dog breeds Ferret models of viral pathogenesis SARS- CoV-2 is transmitted via contact and via the air between ferrets Infection and rapid transmission of SARS- CoV-2 in ferrets Coronavirus rips through Dutch mink farms, triggering culls Minipigs and potbellied pigs as pets in the veterinary practice- a retrospective study Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts Coronavirus disease 2019( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-346819-11fkgzaa | Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis Prediction of protein stability changes for single- site mutations using support vector machines Comparative Protein Structure Modeling Using MODELLER Python: a programming language for software integration and development Systematic validation of protein force fields against experimental data Are Protein Force Fields Getting Better? |
| cord-346819-11fkgzaa | The establishment of reference sequence for SARS- CoV-2 and variation analysis Characterization of the receptor- binding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine The spike protein of SARS- CoV- a target for vaccine and therapeutic development Angiotensin- converting enzyme 2: a functional receptor for SARS coronavirus Can one predict protein stability? |
| cord-346819-11fkgzaa | Why are RNA virus mutation rates so damn high? |
| cord-353524-3w970ycx | Therefore, is there a hope for a Q11 rapid drug to come to the market? |
| cord-353524-3w970ycx | What are the issues and chances for a rapid approval of a new medicine to treat COVID-19? |
| cord-274802-7ioiwsd8 | : what to expect for COVID-19? |
| cord-274802-7ioiwsd8 | COVID-19 Hyperinflammation: What about Neutrophils? |
| cord-274802-7ioiwsd8 | COVID-19 pandemic and the skin: what should dermatologists know? |
| cord-274802-7ioiwsd8 | Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-274802-7ioiwsd8 | How far the lung surfactant system gets affected during severe symptoms? |
| cord-274802-7ioiwsd8 | Lessons from atypical haemolytic uraemic syndrome Complement- mediated endothelial cell damage in immune complex vasculitis of the skin: Ultrastructurallocalization of the membrane attack complex Mannose- Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over- activation The complement system in COVID-19: friend and foe? |
| cord-274802-7ioiwsd8 | On the adaptive immune aspects, what variations exist within population in terms of the proportion of neutralising antibodies? |
| cord-274802-7ioiwsd8 | Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease SARS- CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study Why does COVID-19 disproportionately affect older people? |
| cord-274802-7ioiwsd8 | What are the genetic contributors to susceptibility and resistance to developing COVID-19? |
| cord-274802-7ioiwsd8 | What happens during the period of latency, i.e. between being infected and showing symptoms? |
| cord-274802-7ioiwsd8 | Where and What Is the Evidence? |
| cord-274802-7ioiwsd8 | Why there are a huge population that are asymptomatic carriers? |
| cord-274802-7ioiwsd8 | observational cohort study Loss of smell and taste as symptoms of COVID-19: what does the evidence say? |
| cord-353484-q7d0ysbo | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro First Case of 2019 Novel Coronavirus in the United States Compassionate Use of Remdesivir for Patients with Severe Covid-19 Remdesivir in adults with severe COVID-19: a randomised, double- blind, placebo- controlled, multicentre trial Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-353484-q7d0ysbo | What Do We Know? |
| cord-344714-0cam9ipf | Anti- inflammatory effects of flavonoids in neurodegenerative disorders Phytochemicals in cancer prevention and therapy: truth or dare? |
| cord-344714-0cam9ipf | Coagulation and inflammation cross- talking Dexamethasone in the management of covid-19 Antioxidant polyphenols in cancer treatment: Friend, foe or foil? |
| cord-344714-0cam9ipf | The effect of quercetin on different viruses Activity of some flavonoids against viruses Antiviral effect of flavonoids on human viruses Vanden Berghe, Can ethnopharmacology contribute to the development of antiviral drugs? |
| cord-344714-0cam9ipf | food health dis COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-340305-jtvn9tlm | As the authors suggest, are these examples simply ones of persistence or re- infection? |
| cord-340305-jtvn9tlm | Does neutralization antibody ensure protection? |
| cord-340305-jtvn9tlm | How would this dilemma then be potentially overcome? |
| cord-340305-jtvn9tlm | If neutralizing antibody correlates with protection, is there a threshold at which the prediction can be confident? |
| cord-340305-jtvn9tlm | viral relapse, reinfection or inflammatory rebound? |
| cord-345356-gn1iwis0 | Coronavirus disease Coronavirus vaccine: when will it be ready? |
| cord-345356-gn1iwis0 | What are these pathways? |
| cord-345356-gn1iwis0 | What is the relative contribution of different endocytic pathways to SARS- CoV-2 infection? |
| cord-352230-8mazd3eu | IIB inhibits antibody- dependent enhancement of dengue virus infection Immunomodulation by IVIg and the role of Fc- gamma receptors: classic mechanisms of action after all? |
| cord-352230-8mazd3eu | Is the anti- psychotic, 10-(3-(dimethylamino) propyl) phenothiazine( promazine), a potential drug with which to treat SARS infections? |
| cord-355567-60sfv60p | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-355567-60sfv60p | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-351011-v4zmksio | The pathogenesis and treatment of the` Cytokine Storm'in COVID-19 The many faces of the anti- COVID immune response Neuromechanisms of SARS- CoV-2: A Review Early recovery following new onset anosmia during the COVID-19 pandemic-an observational cohort study Does SARS- Cov-2 invade the brain? |
| cord-351011-v4zmksio | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): The 590 Perspectives of clinical immunologists from China Severe COVID-19 and aging: are monocytes the key? |
| cord-351011-v4zmksio | increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism Protection of LPS- induced murine acute lung injury by sphingosine-1-phosphate lyase suppression Sphingolipids in Ventilator Induced Lung Injury: Role of Sphingosine-1-Phosphate Lyase Endothelial cell infection and endotheliitis in COVID-19 Effective treatment of severe COVID-19 patients with tocilizumab Macrophages: a Trojan horse in COVID-19? |
| cord-327063-ea7a1xfl | Avian influenza and sialic acid receptors: more than meets the eye? |
| cord-327063-ea7a1xfl | Based on SARS- CoV Immunological Studies Is COVID-19 receiving ADE from other coronaviruses? |
| cord-327063-ea7a1xfl | COVID-19: what is next for public health? |
| cord-327063-ea7a1xfl | Companion Animal Pets Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-327063-ea7a1xfl | First respiratory transmitted food borne outbreak? |
| cord-327063-ea7a1xfl | The Indian journal of animal sciences MERS- CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? |
| cord-327063-ea7a1xfl | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-327063-ea7a1xfl | What can animal coronaviruses tell us about emerging human coronaviruses? |
| cord-318204-t024w7h6 | : Is there one? |
| cord-318204-t024w7h6 | A c c e p t e d M a n u s c r i p t 12 Is there a correlation between age and antibody titer? |
| cord-318204-t024w7h6 | Are quantitative serologies helpful? |
| cord-318204-t024w7h6 | Are serologic tests useful to diagnose acute COVID-19? |
| cord-318204-t024w7h6 | Does a positive antibody test mean that a patient is immune? |
| cord-318204-t024w7h6 | Does a positive specimen mean that a patient is infectious? |
| cord-318204-t024w7h6 | Is it worth repeating a test after a patient has tested negative? |
| cord-318204-t024w7h6 | Is point- of- care testing available? |
| cord-318204-t024w7h6 | negative? |
| cord-318204-t024w7h6 | useful? |
| cord-353293-vjdwh19x | Children are not infected, or most of them are asymptomatic, but do they spread the infection in family clusters? |
| cord-353293-vjdwh19x | Do children play a role in this pandemic? |
| cord-353293-vjdwh19x | Do they play a role in the contagion chain? |
| cord-353293-vjdwh19x | The most important open question to be answered is as follows:"Once recovered from COVID-19 what happens to patients, and how has the virus impacted their body?" |
| cord-337825-ujq9mxk7 | Does this peptide loop impact on the entry pathway type of SARS- CoV-2, compared to other known betacoronavirus lineage B? |
| cord-337825-ujq9mxk7 | Is it possible that it invades host cells via additional novel routes, not limited to ACE2? |
| cord-337825-ujq9mxk7 | Is there an S- like protein involved in invasion? |
| cord-337825-ujq9mxk7 | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-337825-ujq9mxk7 | Therefore, which are exactly the cell types that SARS- CoV-2 may attack? |
| cord-337825-ujq9mxk7 | the global RNA virome Classify viruses- the gain is worth the pain Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease Human coronaviruses: what do they cause? |
| cord-350992-l6l24pco | : Is Ferritinophagy the Link? |
| cord-350992-l6l24pco | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-350992-l6l24pco | The authors declare the following financial interests/ personal relationships which may be considered as Of chloroquine and COVID-19 Viral infection and iron metabolism Hepcidin and the iron- infection axis Iron and infection Guidelines for the use and interpretation of assays for monitoring autophagy Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-350992-l6l24pco | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-350992-l6l24pco | Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? |
| cord-350015-mg5wiihj | : why are children overwhelmingly spared? |
| cord-350015-mg5wiihj | A comparative analysis of control measures on- board ship against COVID-19 and similar novel viral respiratory disease outbreak: Quarantine ship or disembark suspects? |
| cord-350015-mg5wiihj | But does it matter? |
| cord-350015-mg5wiihj | COVID-19 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Antibody responses to SARS- CoV-2 in patients of novel coronavirus disease 2019 Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, People's Republic of China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: |
| cord-350015-mg5wiihj | The Pathway to a Universal Influenza Vaccine Age and immunity: What is"immunosenescence Can an effective SARS- CoV-2 vaccine be developed for the older population? |
| cord-350015-mg5wiihj | The ancient and the new": is there an interaction between cytomegalovirus and SARS- CoV-2 infection? |
| cord-354824-7fdcu2f0 | Evaluation of the efficacy and safety of sarilumab in hospitalized patients with COVID-19 Overview of the IL-1 family in innate inflammation and acquired immunity Personalised immunotherapy for SARS- CoV-2( COVID-19) associated with organ dysfunction Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-354824-7fdcu2f0 | Investigating mechanism of Qingfei Dayuan granules for treatment of COVID-19 based on network pharmacology and molecular docking Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and metaanalysis Traditional Chinese herbal medicine as a source of molecules with antiviral activity Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-354824-7fdcu2f0 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology Groups at higher risk for severe illness Coronavirus and COVID-19: who is at higher risk? |
| cord-354824-7fdcu2f0 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-354824-7fdcu2f0 | identifies potential anti- coronavirus drugs Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-314051-dr27bsvt | Can providers safely discontinue infection prevention and control measures? |
| cord-314051-dr27bsvt | Comment faut- il conseiller les patients concernant les résultats de leur test? |
| cord-314051-dr27bsvt | Comment les systèmes de santé gèreront- ils ces résultats? |
| cord-314051-dr27bsvt | How should patients be counselled about their test results? |
| cord-314051-dr27bsvt | How will health systems deal with these results? |
| cord-314051-dr27bsvt | Le personnel médical peut- il en toute sécurité ne prendre aucune mesure de prévention et de contrôle des infections? |
| cord-314051-dr27bsvt | Preoperative SARS- CoV-2 screening: Can it really rule out COVID-19? |
| cord-314051-dr27bsvt | Quel est leur risque de COVID-19 postopératoire? |
| cord-314051-dr27bsvt | Should these patients proceed to surgery? |
| cord-314051-dr27bsvt | What is their risk of postoperative COVID-19? |
| cord-314051-dr27bsvt | devraient- ils subir leur chirurgie? |
| cord-314051-dr27bsvt | la présence de COVID-19? |
| cord-338973-73a7uvyz | Apart from droplet transmission and contact transmission, are there other methods to transmit SARS- CoV-2? |
| cord-338973-73a7uvyz | Can the susceptibility of asymptomatic carriers be judged by detecting the serum reactivity level of N protein? |
| cord-338973-73a7uvyz | Do any environmental factors, such as regional conditions or climate, affect SARS- CoV-2 transmission? |
| cord-338973-73a7uvyz | Do ethnic differences affect the transmissibility and pathogenicity of SARS- CoV-2? |
| cord-338973-73a7uvyz | Does SARS- CoV-2 orf8 and orf10 proteins, which have no homology proteins in SARS- CoV, play roles in the infectivity and pathogenicity of SARS- CoV-2? |
| cord-338973-73a7uvyz | Does traditional Chinese medicine have any effect on the treatment of COVID-19 caused by SARS- CoV-2? |
| cord-338973-73a7uvyz | Is there an effective specific anti- SARS- CoV-2 solution? |
| cord-338973-73a7uvyz | Is there any effect of SARS- CoV vaccine designed according to S protein on SARS- CoV-2? |
| cord-338973-73a7uvyz | What is the effect of the surface epitope and receptor binding domain of S protein of SARS- CoV-2 on the virus'infectivity? |
| cord-338973-73a7uvyz | What is the percentage of COVID-19 patients have been infected with SARS and produced antibodies? |
| cord-347351-emdj66vj | : how much do we really know? |
| cord-347351-emdj66vj | : what does viral RNA load really mean? |
| cord-347351-emdj66vj | A Case Report Surgical mask partition reduces the risk of non- contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019( COVID-19) Australian Government releases face masks to protect against coronavirus Rapid assessment of regional SARS- CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands Universal Masking in Hospitals in the Covid-19 Era Mass masking in the COVID-19 epidemic: people need guidance Covid-19: should the public wear face masks? |
| cord-347351-emdj66vj | A SARS- CoV-2 familial cluster infection reveals asymptomatic transmission to children Familial cluster of SARS- CoV-2 infection associated with a railway journey What settings have been linked to SARS- CoV-2 transmission clusters? |
| cord-347351-emdj66vj | Clinical infectious diseases: an official publication of the Infectious Diseases Society of Viral kinetics of SARS- CoV-2 in asymptomatic carriers and presymptomatic patients Clinical infectious diseases: an official publication of the Infectious Diseases Society of Viral Load Kinetics of SARS- CoV-2 Infection in First Two Patients in Korea A field indoor air measurement of SARS- CoV-2 in the patient rooms of the largest hospital in Iran Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study Environmental contamination by SARS- CoV-2 in a designated hospital for coronavirus disease 2019 Do established infection prevention and control measures prevent spread of SARS- CoV-2 to the hospital environment beyond the patient room? |
| cord-347351-emdj66vj | Temporal dynamics in viral shedding and transmissibility of COVID-19 Clearance and persistence of SARS- CoV-2 RNA in patients with COVID-19 Journal of clinical virology: the official publication of the Pan American Society for Airborne or droplet precautions for health workers treating COVID-19? Transmission routes of respiratory viruses among humans Aerobiology and its role in the transmission of infectious diseases Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations On air- borne infection: study II. |
| cord-347351-emdj66vj | an official publication of the Infectious Diseases Society of How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-347351-emdj66vj | the Spread of the Novel Coronavirus? |
| cord-335122-8s3bcyo8 | : What do we know? |
| cord-335122-8s3bcyo8 | Are HEPA filters required in air filtration/ air purification systems for effective reduction of aerosols generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? |
| cord-335122-8s3bcyo8 | Does aerosol generation differ when debonding is performed with a slow- speed vs. high- speed hand piece, or when debonding is performed with water vs. without water? |
| cord-335122-8s3bcyo8 | How much aerosol is generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | Portable HEPA air filtration system properly situated Are air filtration/ air purification systems effective in reducing aerosols generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | The Journal of Infectious Diseases Is the oral cavity relevant in SARS- CoV-2 pandemic? |
| cord-335122-8s3bcyo8 | The effectiveness of an aerosol reduction device for ultrasonic sealers A study to evaluate and compare the efficacy of preprocedural mouthrinsing and high volume evacuator attachment alone and in combination in reducing the amount of viable aerosols produced during ultrasonic scaling procedure Efficacy of High- volume Evacuator in Aerosol Reduction: Truth or Myth? |
| cord-335122-8s3bcyo8 | What PPE is most appropriate during aerosol generating procedures vs. non- aerosol generating procedures? |
| cord-335122-8s3bcyo8 | When should PPE be discarded and replaced during patient care? |
| cord-335122-8s3bcyo8 | o f How much time should be allocated between patients when aerosol generating procedures are performed? |
| cord-356009-emn2w8if | : Does SARS- CoV-2 Cause Viral Cystitis? |
| cord-356009-emn2w8if | However, it is important to notice that it is the naso- pharyngeal specimens,? |
| cord-356009-emn2w8if | Moreover, the findings in our review? suggest that a larger population size may reveal more positive urinary cases possibly by? |
| cord-356009-emn2w8if | Moreover, the findings in our review? suggest that a larger population size may reveal more positive urinary cases possibly by? |
| cord-356009-emn2w8if | Our review concludes that not only the SARS- CoV-2 can be excreted in the urine in eight? |
| cord-356009-emn2w8if | What Specimen Urologists Should Be Most Concerned About? |
| cord-356009-emn2w8if | What kind of systematic review should I conduct? |
| cord-356009-emn2w8if | percent of patients but also its incidence may have associations with the severity of the? systemic disease, ICU admission, and fatality rates. |
| cord-350959-bsbz3a1l | : extra caution needed for patients with diabetes Are patients with cancer at higher risk of COVID-19? |
| cord-350959-bsbz3a1l | : what we know? |
| cord-350959-bsbz3a1l | Coronavirus COVID-19 exaggerated threat U.S opinion by gender China: gender distribution of novel coronavirus patients Italy: coronavirus cases distribution by gender Who is getting sick? |
| cord-350959-bsbz3a1l | I Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-350959-bsbz3a1l | Infectious mononucleosis, other infections and prostate- specific antigen concentration as a marker of prostate involvement during infection Evidence for gastrointestinal infection of SARS- CoV-2 Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely? |
| cord-350959-bsbz3a1l | SARS- CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China Immunotherapy for prostate cancer: where we are headed The role of telehealth in the medical response to disasters Virtually perfect? |
| cord-350959-bsbz3a1l | Telemedicine for COVID-19 Coronavirus pandemic in South Korea Coronavirus: why did infections shoot up in South Korea? |
| cord-350959-bsbz3a1l | a systematic review of the evidence Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and metaanalysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-350959-bsbz3a1l | micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells Influenza vaccination and chemotherapy: a shot in the dark? |
| cord-279255-v861kk0i | ( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-279255-v861kk0i | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
| cord-279255-v861kk0i | : what have we learned? |
| cord-279255-v861kk0i | : what is the role of radiologists? |
| cord-279255-v861kk0i | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-279255-v861kk0i | Can SARS- CoV-2 infection be acquired in utero? |
| cord-279255-v861kk0i | Can cats become infected with Covid-19? |
| cord-279255-v861kk0i | Can companion animals become infected with Covid-19? Leading veterinary diagnostic company |
| cord-279255-v861kk0i | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-279255-v861kk0i | However, the real question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to occur within the next 5 to 10 years or perhaps sooner? |
| cord-279255-v861kk0i | Influenza Other Respir Viruses Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | More definitive evidence is needed Wuhan virus: Chinese animal markets reopened with almost no precautions China must close down"wet markets Will they ever learn? |
| cord-279255-v861kk0i | Rational vaccine design in the time of COVID-19 Bacillus Calmette Guérin( BCG) vaccination use in the fight against COVID-19-what's old is new again? |
| cord-279255-v861kk0i | Reply to"Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | The establishment of reference sequence for SARS- CoV-2 and variation analysis Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-279255-v861kk0i | The next big threat to global health? |
| cord-279255-v861kk0i | What do we know about the SARS- CoV-2 coronavirus in the environment? |
| cord-279255-v861kk0i | What is the potential impact of the Amazon wildfires on vector- borne and zoonotic emerging diseases? |
| cord-279255-v861kk0i | and now the 2019-novel CoV: have we investigated enough about coronaviruses? |
| cord-279255-v861kk0i | e12591 Infection and rapid transmission of SARS- CoV-2 in ferrets Current therapeutic applications and pharmacokinetic modulations of ivermectin Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? |
| cord-279255-v861kk0i | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-279255-v861kk0i | proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China Emerging viruses without borders: the Wuhan coronavirus China coronavirus: what do we know so far? |
| cord-342756-rgm9ffpk | -What happens next? |
| cord-342756-rgm9ffpk | : what to expect for COVID-19? |
| cord-342756-rgm9ffpk | COVID-19 and diabetes: Can DPP4 inhibition play a role? |
| cord-342756-rgm9ffpk | COVID-19, SARS and MERS: are they closely related? |
| cord-342756-rgm9ffpk | DPP4 inhibition: preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-342756-rgm9ffpk | Protein- protein interactions of viroporins in coronaviruses and paramyxoviruses: new targets for antivirals? |
| cord-342756-rgm9ffpk | The importance of hypertension as a risk factor for severe illness and mortality in COVID-19 Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Diabetes is a risk factor for the progression and prognosis of COVID-19 Older people and COVID-19: isolation, risk and ageism Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow- up Drug repositioning: identifying and developing new uses for existing drugs Drug repurposing from the perspective of pharmaceutical companies Drug repurposing: progress, challenges and recommendations Emerging virus diseases: can we ever expect the unexpected? |
| cord-342756-rgm9ffpk | and COVID-19: serendipity or opportunity for intervention? |
| cord-342756-rgm9ffpk | should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-342756-rgm9ffpk | what lessons have we learned? |
| cord-332778-rf47ptj6 | ( 2) are ICIs, in particular, a risk factor for SARS- CoV-2 infection rate and/or development of severe symptoms? |
| cord-332778-rf47ptj6 | : What do we really know? |
| cord-332778-rf47ptj6 | About COVID-19 Potential Antiviral Drugs for SARS- Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research Acute respiratory failure in COVID-19: Is it"typical"ARDS? |
| cord-332778-rf47ptj6 | Based on these observations, is it acceptable to continue ICIs to cancer patients during COVID-19 acute pandemic phase? |
| cord-332778-rf47ptj6 | Based on these observations, is it acceptable to continue ICIs to cancer patients during COVID-19 acute pandemic phase? |
| cord-332778-rf47ptj6 | Do ICIs compromise cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-332778-rf47ptj6 | Do checkpoint inhibitors compromise the cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-332778-rf47ptj6 | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-332778-rf47ptj6 | From these two studies some questions remain unsolved:( 1) is any type of anti- cancer therapy a positive or a negative risk factor for SARS- CoV-2 infection? |
| cord-332778-rf47ptj6 | Is ICIs administration harmful or beneficial for cancer patients during the COVID-19 pandemic? |
| cord-332778-rf47ptj6 | Is Immune Checkpoint Inhibitors- Based Immunotherapy Harmful or Beneficial? |
| cord-332778-rf47ptj6 | Or, on the contrary, do ICIs potentiate their immune system? |
| cord-332778-rf47ptj6 | The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? |
| cord-332778-rf47ptj6 | The spark that ignites the fire? |
| cord-345371-pjbviagq | : Are we asking the right questions? |
| cord-345371-pjbviagq | An Individual Patient Data Systematic Review Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| cord-345371-pjbviagq | An Overview of Severe Acute Respiratory Syndrome- Coronavirus( SARS- CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad- Spectrum Therapeutic Strategy Old drugs as lead compounds for a new disease? |
| cord-345371-pjbviagq | Baricitinib: a chance to treat COVID-19? |
| cord-345371-pjbviagq | Bleeding and Thrombotic Manifestations of SARS- CoV2 Infection COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow- up Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? |
| cord-345371-pjbviagq | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-345371-pjbviagq | Increased cardiovascular mortality in African Americans with COVID-19 Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis? |
| cord-345371-pjbviagq | Inhibitory Mechanisms A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Owa Lopinavir/ ritonavir use in Covid-19 infection: is it completely non- beneficial? |
| cord-345371-pjbviagq | Is teicoplanin a complementary treatment option for COVID-19? |
| cord-345371-pjbviagq | Justified? |
| cord-345371-pjbviagq | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-345371-pjbviagq | The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells Cardiac arrest caused by nafamostat mesilate Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy Potential new treatment strategies for COVID-19: is there a role for bromhexine as add- on therapy? |
| cord-345371-pjbviagq | Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? |
| cord-345371-pjbviagq | Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors Angiotensin- I converting enzyme inhibitors as potential anti- angiogenic agents for cancer therapy Our ACE in the HOLE: Justifying the Use of Angiotensin- converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy Vascular endothelial growth factor( VEGF) in acute lung injury( ALI) and acute respiratory distress syndrome( ARDS): paradox or paradigm? |
| cord-345371-pjbviagq | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-334773-yw2qgv13 | COVID-19 and diabetes management: What should be considered? |
| cord-334773-yw2qgv13 | COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-334773-yw2qgv13 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-334773-yw2qgv13 | Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms Does high cardiorespiratory fitness confer some protection against pro- inflammatory responses after infection by SARS- CoV-2? |
| cord-334773-yw2qgv13 | Dipeptidyl peptidase 4 distribution in the human respiratory tract implications for the middle east respiratory syndrome COVID-19 and diabetes: can DPP4 inhibition play a role? |
| cord-334773-yw2qgv13 | Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? |
| cord-334773-yw2qgv13 | F1000Prime Rep Is there a role for statin therapy in acute viral infections? |
| cord-334773-yw2qgv13 | Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses COVID-19 and comorbidities: a role for dipeptidyl peptidase 4( DPP4) in disease severity? |
| cord-334773-yw2qgv13 | Hollingsworth, How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-334773-yw2qgv13 | Is the ACE2 overexpression a risk factor for COVID-19 infection? |
| cord-334773-yw2qgv13 | Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in Potential effects of coronaviruses on the cardiovascular system: a review Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-334773-yw2qgv13 | Should anti- diabetic medications be reconsidered amid COVID-19 pandemic? |
| cord-334773-yw2qgv13 | Sliding Scale Insulin Use: Myth or Insanity? |
| cord-334773-yw2qgv13 | The etiology of lower respiratory tract infections in people with diabetes Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus( MERS- CoV): a systematic review and meta- analysis Benefits of flu vaccination for persons with diabetes mellitus: a review COVID-19 and diabetes: knowledge in progress Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study Influenza virus and glycemic variability in diabetes: a killer combination? |
| cord-334773-yw2qgv13 | Worse progression of COVID-19 in men: is testosterone a key factor? |
| cord-334773-yw2qgv13 | inhibitors/ angiotensin receptor blockers have a biphasic effect? |
| cord-334773-yw2qgv13 | medRxiv ACE2 in BRain physiology and pathophysiology: evidence from transgenic animal models ACE2 and diabetes: ACE of ACEs? |
| cord-334773-yw2qgv13 | the conundrum Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-323905-ayufx3wv | , should we cancel the operation? |
| cord-323905-ayufx3wv | -Modification or reorganization of hospital wards( patient density, bed density, medical and nursing staff density, etc.)? |
| cord-323905-ayufx3wv | -Should we only select patients as candidates who also consent to regional/ spinal anaesthesia? |
| cord-323905-ayufx3wv | Are new triage/ patient selection criteria needed for hip and knee arthroplasty patients once elective surgery is resumed? |
| cord-323905-ayufx3wv | Are special adjustments needed for post- op SARS- CoV-2 prophylaxis? |
| cord-323905-ayufx3wv | Are special adjustments needed for post- op SARS- CoV-2 prophylaxis? |
| cord-323905-ayufx3wv | Is pre- operative tracking of patients, staff and relatives necessary? |
| cord-323905-ayufx3wv | Is there a need for extra disinfecting environmental procedures in between surgeries? |
| cord-323905-ayufx3wv | Patient numbers in the clinical areas( wards, waiting areas, outpatient clinics) should be halved, with the patients spaced at least 2 m apart-Separation of elective and trauma orthopaedic surgery( with regard to the general orthopaedic departments)? |
| cord-323905-ayufx3wv | Should relatives/ visitors or other supportive personnel be allowed onto the orthopaedic wards and operating suite? |
| cord-323905-ayufx3wv | Should spinal anaesthesia be routine? |
| cord-323905-ayufx3wv | Should spinal anaesthesia be routine? |
| cord-323905-ayufx3wv | What are the priority indications for elective adult hip and knee reconstruction? |
| cord-323905-ayufx3wv | What is the advice for patients who develop SARS- CoV-2 symptoms? |
| cord-323905-ayufx3wv | What is the advice for patients who develop SARS- CoV-2 symptoms? |
| cord-323905-ayufx3wv | What is the appropriate pre- operative clinical and laboratory screening and timeline for patients? |
| cord-323905-ayufx3wv | What is the appropriate preoperative clinical and laboratory screening and timeline for patients? |
| cord-323905-ayufx3wv | What is the impact of delaying hip and knee arthroplasty for the patients themselves and for society? |
| cord-323905-ayufx3wv | What is the role of outpatient hip and knee arthroplasty/ enhanced recovery protocols in light of the SARS- CoV-2 pandemic? |
| cord-323905-ayufx3wv | What kind of back- up plan is needed to guarantee quality care and patient safety in this pandemic situation? |
| cord-323905-ayufx3wv | What role do ultra- clean operating theatres, orthopaedic exhaust suits and ultraviolet light systems play in both the wards/ beds and the theatre? |
| cord-323905-ayufx3wv | When should elective hip and knee arthroplasty be resumed? |
| cord-346539-kxnrf5g5 | -An updated interim review and lessons from SARS- CoV and MERS- CoV Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-346539-kxnrf5g5 | 152 pandemic? |
| cord-346539-kxnrf5g5 | 50,153 endotype is associated with severe asthma in obese patients, are obese asthmatic patients more likely to develop severe COVID-19? |
| cord-346539-kxnrf5g5 | : why might they be hazardous? |
| cord-346539-kxnrf5g5 | Advances in Diagnosis and Treatment BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-346539-kxnrf5g5 | Advice for Healthcare Professionals Treating People with Asthma( adults) in relation to COVID-19 COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids Asthma and COVID-19: is asthma a risk factor for severe outcomes? |
| cord-346539-kxnrf5g5 | Covid-19-Navigating the Uncharted COVID-19, SARS and MERS: are they closely related? |
| cord-346539-kxnrf5g5 | Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS- CoV-2 infection is associated with disease severity and fatal outcome Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-346539-kxnrf5g5 | IgG1(+) B- cell immunity predates IgE responses in epicutaneous sensitization to foods Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? |
| cord-346539-kxnrf5g5 | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-346539-kxnrf5g5 | Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-346539-kxnrf5g5 | The Multifaceted B Cell Response in Allergen Immunotherapy COVID-19 Autopsies EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity Lung eosinophils- A novel"virus sink"that is defective in asthma? |
| cord-346539-kxnrf5g5 | The iceberg of COVID-19: are there asymptomatic cases below the surface? |
| cord-346539-kxnrf5g5 | These zoonotic beta- coronaviruses share structural and genomic similarities that are useful to patients? |
| cord-346539-kxnrf5g5 | Twelve Years after Pathogenesis of Acute Respiratory Distress Syndrome Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives-a report of the 1 COVID-19 pneumonia: ARDS or not? |
| cord-346539-kxnrf5g5 | What specific therapies can be suggested for ARDS? |
| cord-346539-kxnrf5g5 | Which cytokines are most elevated during CSS? |
| cord-346539-kxnrf5g5 | Will helminth co- infection modulate COVID-19 severity in endemic regions? |
| cord-346539-kxnrf5g5 | [ 277][ 278][ 279] What is the evidence supporting social distancing and face mask to prevent SARS- CoV-2 infection? |
| cord-346539-kxnrf5g5 | an urgent public health research priority Is ethnicity linked to incidence or outcomes of covid-19? |
| cord-346539-kxnrf5g5 | pandemic? |